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ABSTRACT 
Streptococcus pyogenes is a versatile human pathogen causing a wide 
array of diseases ranging from uncomplicated throat and skin infections to 
invasive life-threatening diseases with a mortality rate of up to 60%. It is 
ranked number nine on the list of worst infectious diseases world wide, 
causing 500 000 deaths yearly. The work presented in this thesis was 
initiated upon finding viable bacteria in tissue macrophages of patients with 
severe S. pyogenes infections. This intracellular bacterial reservoir was 
linked to prolonged bacterial persistence at the tissue site. It was therefore 
of interest to investigate how the bacteria could survive within professional 
phagocytes that have evolved for the specific purpose of degrading 
invading microbes. Hence, the overall aim of the thesis was to decipher 
streptococcal survival strategies in macrophages. 
 
Certain bacterial serotypes are more efficient in causing invasive infections 
than others, as they are equipped with special tools to facilitate invasion 
and survival. We have identified the bacterial M1-protein as an important 
factor for intracellular survival in macrophages. Studies on entry and 
intracellular trafficking revealed that the bacteria are residing inside 
membrane-bound compartments, which do not fuse with the lysosomal 
compartments; thus enabling persistence and replication. Thereto, M1-
protein was shown to suppress the host-inflammatory response upon S. 
pyogenes infection. Regulation of bacterial intracellular signaling is vital for 
bacterial survival and it also affects host responses. Data are supporting a 
role for the two-component gene regulatory system, Ihk/Irr, during adaption 
to the intracellular environment while another regulatory system, CovR/S, 
possibly facilitates infectivity of disseminating bacteria. In addition, we show 
that the arachidonic acid metabolite, prostaglandin E2, which is produced by 
host cells upon infection, has a negative impact on macrophage bactericidal 
responses, thus enabling bacterial survival inside the host cell.  
 
The studies comprised in this thesis contribute to a deeper understanding of 
the host-pathogen interplay during severe S. pyogenes infections, in 
particular with regards to mechanisms contributing to intracellular survival in 
host cells. The results demonstrate that S. pyogenes ability to persist within 
macrophages is enabled through distinctly regulated mechanisms involving 
both host and bacterial factors.  
 
S. pyogenes used to be considered as an extracellular pathogen, however, 
it is becoming increasingly apparent that it is important to consider also an 
intracellular source; thus affecting choice of antimicrobial agents. In 
addition, work presented in this thesis has identified several novel targets, 
both on the bacterial side and on the host side, which may be suitable 
candidates for intervention.  
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1 INTRODUCTION	  	  
	  
1.1 	  HOST	  DEFENCE	  MECHANISMS	  AGAINST	  PATHOGENS	  
The function of the immune system is to sense and protect the host from 
foreign substances. It is a delicate machinery with a variety of adaptations 
depending on the site of invasion and the type of invader. The primary defense 
is called the innate immune system and consists of several branches. Skin and 
mucosal surfaces lining the cavities in the body represent a major barrier for 
invading pathogens. However, sometimes, these barriers are compromised, 
allowing the intruder to become invasive, whereafter it comes in contact with 
the cellular immune system.  
 
 
1.1.1 Cellular	  components	  of	  the	  immune	  system	  
Cellular immunity is divided into a primary and a secondary response upon 
challenge. The primary immune response is the first line of defense that 
recognizes conserved microbial patterns and cannot differentiate between 
small variations in foreign particles and it does not have the capacity to 
memorize a pathogen exposure. It is activated within hours of infection and 
comprises phagocytes, such as macrophages, dendritic cells (DCs), and 
polymorphonuclear cells (PMNs), and natural killer (NK) cells. Antimicrobial 
peptides, components of the complement system and cytokines are also part of 
the innate immunity (1).  
 
The second part of the immune response, which kicks in at a later stage, up to 
days after infection, is characterized by immunological memory and is called 
the adaptive immunity. It can be divided into two parts, the humoral and the 
cell-mediated response. The main effector cells are the lymphocytes, which are 
divided into two groups; B lymphocytes, the antibody-producing cells that 
mediate the humoral immunity and T lymphocytes that provide the cell-
mediated immunity (2). Antibodies secreted by B cells recognize microbes and 
neutralize for example secreted toxins and target the microbes for destruction 
by effector cells (3). Adaptive immunity is initiated by lymphocyte recognition of 
a foreign antigen. Antigen-presenting cells (APCs), namely macrophages, DCs 
and B cells are cells that upon encounter with a foreign particle, phagocytose 
and degrade it. During the process of degradation, peptides are derived which 
can be presented on MHC class I or class II molecules. MHC molecules with 
the processed peptide on the APCs bind to the T cell receptor on T cells, which 
then become activated and gain effector functions, such as secretion of 
cytokines and cytotoxicity. There are two types of T cells, CD4+ T cells that are 
activated by APCs presenting antigen on MHC class II molecules, mainly 
derived from exogenous antigens, and CD8+ T cells that are activated by 
antigens on MHC class I molecules, derived from both exogenous and 
endogenous antigens such as bacteria, viruses or tumor cells (2, 4). Antigens 
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derived from intracellular bacteria that are residing inside phagosomes of host 
cells are presented on MHC class II, while antigens from bacteria escaping 
from the phagosome and consequently residing in the cytosol, are presented 
on MHC class I molecules (4). CD4+ T cells generally functions as T helper (TH) 
cells secreting cytokines, while CD8+ T cells develop into T cytotoxic (Tc) cells 
(1, 2).  
 
Repeated exposure to a microbe results in a faster and more prominent 
adaptive immune response since it is provided with memory lymphocytes that 
recognize the antigen (5). This is in contrast to the innate immune response 
that will always react with the same power. The ability of T and B cells to 
express receptors that can discriminate between small differences in structure 
between antigens forms the basis of the concept of diversity. This ability 
differentiates receptors of cells of the innate immunity, which can only 
recognize a limited number of patterns shared by several microbes. It is 
estimated that the innate immune system can recognize 103 different patterns 
while the adaptive immune system can recognize 107 or more specific antigens 
(2). Table 1 presents general characteristics of the innate and the adaptive 
immune system. 
 
 
Table 1. Selected basal features of innate and adaptive immunity. 
Adapted from Abbas et al., Cellular and Molecular Immunology, Fifth edition, 2005 (2). 
 
 
1.1.1.1 Pattern-­‐associated	  molecular	  patterns	  and	  their	  receptors	  
 
Upon encounter with a pathogen, innate immune cells recognize microbial 
structures on the intruder known as pathogen-associated molecular patterns 
(PAMPs). The receptors on immune cells recognizing the PAMPs are called 
pattern recognition receptors (PRRs). They recognize a variety of PAMPs 
including double-stranded RNA from replicating viruses, DNA from bacteria, 
lipopolysaccharide (LPS) expressed by Gram-negative bacteria and 
lipoteichoic acids (LTA) from Gram-positive bacteria (6). Moreover, each type 
of PAMP is recognized by different receptors on host cells in the tissue or in the 
circulation (2, 7). The most common receptor type is Toll-like receptor (TLR) 
family (8), which comprises 10 known receptors in humans and 12 in mice. 
About half of the TLRs are expressed on the cell surface enabling recognition 
of PAMPs from extracellular bacteria, fungi and protozoa. These include TLR 1, 
Characteristics Innate immunity Adaptive immunity 
Specificity For structures shared by 
groups of related microbes 
For antigens of microbes  
Diversity Limited Very large 
Memory None Yes 
Time to action Within hours Within days 
Components   
Physical and 
chemical barriers 
Skin; mucosal epithelia; 
antimicrobial compounds 
Lymphocytes in epithelia; antibodies 
secreted at epithelial surfaces 
Blood proteins Complement Antibodies 
Cells Macrophages, DCs PMNs, NK 
cells 
T and B lymphocytes 
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2, 4, 5 and 6, while the remaining TLRs (3, 7, 8, 9) are located inside the cells 
in endosomes/lysosomes where they recognize nucleic acid PAMPs from 
various viruses and bacteria (9). TLR10 is expressed on the surface; however, 
its activating ligand remains unknown. TLR activation generally induces 
transcription of inflammatory cytokines. Other membrane-bound receptor types 
are mannose receptor (MR) and mannose-binding lectin (MBL) receptor. 
Moreover PPRs called NOD (nucleotide-binding oligomerization domain)-like 
receptors (NLRs) are present in the cytoplasm where they recognize various 
PAMPs from bacteria, viruses and fungi. Recognition of a PAMP by an NLR 
can lead to activation of the NF-κB (Nuclear factor kappa B) or MAP-kinase 
pathway inducing transcription of pro-inflammatory cytokines (6). Recently, 
numerous studies have reported that also bacterial RNA in the cytoplasm, 
identified by RIG-I or MDA-5 receptors, can induce type I interferon responses, 
something that previously has been thought of as a strictly anti-viral response 
(10). Triggering of TLRs induces a wide range of responses from secretion of 
type I interferons and induction of an antiviral state to macrophage activation 
(2).  
 
 
1.1.1.2 	  The	  complement	  system	  
 
Another important system involved in both innate and adaptive immunity is the 
complement system. It consists of several plasma proteins that upon activation 
by pathogens carry out several central functions in the immune response, 
including:  
 
• causing lysis of cells, bacteria and viruses  
• targeting antigens for subsequent phagocytosis by opsonization  
• binding to specific complement receptors on host cells to induce cellular 
functions, such as secretion of inflammatory molecules  
• performing clearance of immune complexes in the circulation  
 
The proteins comprising the complement system are circulating in an inactive 
state in the serum. Upon activation, several factors assemble into a functional 
pore forming membrane attack complex (MAC), which causes lysis of the 
target. Activation occurs via three different mechanisms: 1) binding of C1 
complex to the FcRs of antibodies attached to pathogenic surfaces. 2) 
recognition of PAMPs, or 3) binding of MBL to the pathogen which acts as an 
opsonin (11, 12).   
 
 
1.1.1.3 	  Cytokine	  responses	  during	  infection	  
 
Activation of the immune system results in production of a variety of cytokines 
inducing different effector functions. TH cells are secreting cytokines that can 
direct the type of immune response that is mediated by effector cells 
participating in the host response. A TH1 response leads to a pro-inflammatory 
cytokine profile that supports inflammation and activates macrophages and Tc 
while a TH2 response mainly activates B cells and immune responses that 
depend on antibodies (13).  
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TNF-α and IL-1β are hallmark mediators of immune activation and are secreted 
by a variety of cells upon infection. They are both potent pleiotropic cytokines 
that stimulate activation of cells and TNF-α is responsible for many of the 
systemic complications seen in severe infections such as sepsis and toxic 
shock (14, 15). IL-12 is inducing IFN-γ secretion and subsequent macrophage 
activation to kill intracellular pathogens. In addition, IL-12 enhances the cytolytic 
function of NK cells and CD8+ T cells (16, 17). Secretion of type I interferons 
such as IFN-α and IFN-β are important tools to keep control of viral infections 
(2, 18). IL-6 is involved in promoting adaptive immunity by inducing proliferation 
and antibody production of B cells (12). In summary, upon encounter of a 
foreign particle, the immune system is activated and many factors are secreted 
to promote specific responses depending on the invader. However, when an 
immune reaction has been initiated, several cytokines are secreted to regulate 
and confine the host cell responses through different mechanisms, such as 
inhibition of IL-12 production, promoting down-regulation of MHC class II 
molecule expression and limiting proliferation and activation of effector 
molecules. This is maintained by for example IL-10 and TGF-β (1, 2). 
 
 
1.1.2 The	  macrophage	  and	  its	  role	  during	  infection	   
Macrophages are important cells of the immune system and they have an 
essential role in this thesis. They have the capacity to engulf and degrade 
pathogens as well as to present antigens to T cells and thereby initiate a 
powerful activation of the adaptive immune response. This section comprises a 
detailed description of macrophage effector functions during infection. 
 
 
1.1.2.1 Pattern	  recognition	  receptors	  
	  
Recognition of a pathogen occurs via an array of receptors expressed on the 
cellular membrane. Interaction with a pathogen can occur directly via PAMPs 
and PRRs or indirectly via opsonins on the pathogenic surface. Opsonins 
include for example antibodies, which are recognized by the Fc-receptors 
(FcRs) and complement components that are recognized by the complement 
receptors (CRs). Most microbial structures are recognized by more than one 
receptor, and some receptors may also interact with each other. Each receptor 
has a different role during the process, some mediate adhesion while others 
are part of the internalization process and certain receptors are involved in 
both. An example is ligation of the fibronectin receptor at the surface of the 
macrophage, which induces signaling and activation of the otherwise inactive 
complement receptor CR3 to mediate phagocytosis (19, 20). Macrophages 
express a family of receptors called scavenger receptors, which upon ligation 
can induce phagocytic uptake. They differ from FcRs and CRs since they can 
recognize and bind their target without opsonins. The most well known 
receptors are scavenger receptor A and macrophage receptor with collagenous 
structure, which recognize many bacterial ligands including LTA on Gram-
positive bacteria and the lipid A component of LPS on Gram-negatives (21). 
The c-type lectin domain receptors identify carbohydrates on pathogens. One 
example is the MR, which has been shown to bind the bacterial cell wall 
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glycolipid mannosylated lipoarabinomannan (ManLam) of Mycobacteria and 
thereby induce bacterial uptake (22). 
	  
 
1.1.2.2 	  Maturation	  of	  the	  phagosome	  
 
Upon recognition and uptake of pathogens, the macrophage induces a variety 
of effector functions. At first the intruder is surrounded by a membrane 
structure, which forms the vesicle, called the phagosome. Initially it contains 
extracellular fluid and is not harmful to the pathogen. However, 
phagolysosomal maturation is instantly initiated, as this is the default 
endosomal-lysosomal degradation pathway. Consequently, many intracellular 
pathogens have developed mechanisms to avoid this pathway, which is further 
described in section 1.3.1.2.  
 
Maturation of the phagosome includes recruitment and fusion of vesicles 
containing hydrolytic enzymes and protons, and the pH of the phagosome is 
constantly decreasing during progression to the phagolysosome (Figure 1).  
 
Figure 1. General overview of phagosomal maturation.  
 
 
Recruitment of vesicles is maintained by small guanosine triphosphatases 
(GTPases). The phagosome is quickly becoming an early endosome through 
fusion events organized by the GTPase Rab5 (23) using several effectors such 
as early endosomal antigen 1 (EEA-1) and soluble NSF-attachment protein 
receptor proteins (SNARE), which mediate docking and fusion of cellular 
membranes. EEA-1 is thought to act as a bridge that brings early endosomes 
to incoming endocytic vesicles (24). The pH of the early endosome is mildly 
acidic (pH 6.1-6.5) and has a weak hydrolytic activity (25). In addition, 
membrane parts of the phagosome are recycled to the plasma membrane via 
fission events governed by coat protein 1 (COP1), Arp and GTPases such as 
Rab11 (26, 27). When these recycling proteins are removed, the phagosome 
progress to a later stage called the late endosome. It is characterized by an 
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increase in hydrolytic enzymes and a lower pH ranging from 5.5-6.0, through 
acquisition of a proton-pumping vacuolar (V)-ATPases (28) and fusion with 
lysosome associated membrane proteins (LAMPs) (29). Formation of the late 
endosome is regulated by Rab7 GTPases that coordinate the traffic between 
endosomes and lysosomes (30). The final maturation stage is the 
phagolysosome, where pathogens are degraded in a lumen that has been 
reported to be as low as pH 4.5 (31). The acidity is created by accumulation of 
V-ATPases and in addition the acidity activates maturation of hydrolytic 
enzymes such as endopeptidases and hydrolases. These enzymes are 
produced in a distinct order, where cathepsin H is predominant in early 
phagosomes while cathepsin S is more common in late phagosomes (32).  
 
 
1.1.2.3   Reactive	  oxygen	  species	  and	  antimicrobial	  proteins	  
 
Bacterial killing is also achieved by reactive oxygen species (ROS), produced 
by the NADPH oxidase 2 (NOX2). When activated, NOX2 transfers electrons 
from cytosolic NADPH to molecular oxygen, releasing O2- into the phagosomal 
lumen. Inside the phagosome O2- forms H2O2, which again reacts with O2-, 
generating hydroxyl radicals and singlet oxygen (33). These highly reactive 
ROS efficiently kill the pathogens inside the phagosome. In addition to ROS, 
macrophages produce nitric oxide (NO) and reactive nitrogen species (RNS). 
NO is produced upon activation of the inducible nitric oxide synthase (iNOS) by 
pro-inflammatory cytokines. In contrast to ROS, NO is produced in the cytosol 
but can cross the phagosomal membrane where it reacts with ROS resulting in 
highly toxic compounds (34).  
 
In addition, macrophages have a variety of antimicrobial effector molecules, 
including antimicrobial peptides, scavenger molecules and ion transporters. 
They can be divided into two functional groups; one that limits bacterial growth, 
bacteriostatic, and one that induces bacterial lysis, bacteriocidal. To affect the 
bacterial growth, scavenger molecules can be transferred into the phagosome, 
such as lactoferrin that bind available Fe2+, which is important for some 
bacterial species (35). Another mechanism is to insert transporters that export 
divalent cations such as Fe2+, Zn2+ and Mn2+ important for house keeping 
genes and virulence (36). Antimicrobial peptides are effector molecules that 
target the microbial membrane to induce bacterial lysis. They also possess a 
variety of immunomodulatory functions stimulating for example cytokine release 
and chemotaxis (37, 38). 
 
 
1.1.2.4 	  Autophagy	  
 
The autophagosome is a machinery used to degrade cellular rest products by 
collecting them in a double membrane organelle that is transported to the 
lysosome forming an autolysosome. This system can be utilized to eliminate 
cytosolic pathogens since a number of invaders have evolved ways to escape 
from the endosomal-lysosomal pathway in to the cytosol (39, 40). The 
autophagosome is formed by rough endoplasmic reticulum (ER) via 
(Autophagy-related) Atg1 and Atg14 regulatory genes and is marked by light 
chain 3 (LC3) (41). Apart from degrading the pathogen, the autophagy system 
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also mediates additional immune effector functions such as increasing 
endogenous cytoplasmic presentation of antigens via major histocompatibility 
complex (MHC) class II (42). Intracellular pathogens that are captured by 
autophagy include Mycobacterium (43), Francisella (44) and Listeria (45). 
Interestingly, polymorphisms in an autophagy regulatory gene have been linked 
to predisposition to tuberculosis and to the chronic inflammatory bowel disease, 
Crohn’s disease, in humans (46, 47). In addition, in vivo animal models confirm 
the importance of functional autophagic regulators during bacterial infections 
(48).  
 
 
1.1.2.5 	  Macrophage	  polarization	  
 
Similarly to the TH1 and TH2 responses of T cell polarization, macrophages can 
be divided into M1 and M2 phenotype, with specific effector functions, 
depending on the signaling molecules in the surrounding environment (Figure 
2)(49, 50). The classical M1 response is triggered by microbial products or IFN-
γ, inducing an anti-microbial response with secretion of for example IL-12, IL-
23, an increased capacity to present antigens and to produce ROS (51). The 
alternative activation of macrophages is triggered by mediators such as IL-4, 
IL-13, IL-10, TLR-ligands and prostaglandins inducing a M2 type of 
macrophage (52, 53). The M2 macrophages are poorly bactericidal and several 
pathogens induce this phenotype to control the host cell response (54, 55). It 
was recently reported that polymorphism in a transcription factor regulating 
macrophage polarization leads to higher susceptibility of autoimmune diseases 
resulting from increased inflammation (56).  
 
 
 
 
 
 
Figure 2. General characteristics of M1 and M2 polarization.  
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1.1.2.6 NF-­‐κB	  activation	  
 
Recognition of pathogens by the different PRRs involves, in the majority of 
cases, signaling through the adaptor molecule myeloid differentiation primary-
response gene (MyD88) (57). Signaling via MyD88 eventually leads to 
activation of the cytosolic NF-κB, which regulates effector functions of both 
innate and adaptive immunity. There are five different mammalian NF-κB 
proteins, p65/relA, RelB, c-Rel, p50/p105 and p52/p100. They form hetero- and 
homodimers that depending on the constellation result in differential signaling. 
NF-κB is also equipped with negative regulators, the p50 and p52 which act as 
repressors and thereby inhibit inflammatory responses (58). NF-κB proteins are 
present in the cytoplasm in an inactive state, which is maintained through 
association with inhibitory IκB proteins, thereby limiting nuclear access. Upon 
stimulation of the cell, the IκB protein is phosphorylated and subsequently 
degraded, thus releasing NF-κB, which translocates to the nucleus and induces 
gene transcription of inflammatory effector molecules (59, 60). Interestingly, 
accumulation of p50 homodimers have been reported in LPS-tolerent 
monocytes in septic patients and in M2 polarized macrophages (50, 61, 62).  
 
 
1.1.2.7 	  Prostaglandin	  E2	  during	  immune	  responses	  
 
Prostaglandin E2 (PGE2) is produced by a wide array of cells, including 
macrophages, and has been shown to affect immune responses during 
infection and inflammation (63). It is dependent on the inducible enzyme 
cyclooxygenase (COX). PGE2 acts via G-protein-coupled receptors, called E 
prostanoid (EP) receptors. Engagement of these receptors results in different 
effector functions depending on the cell type, receptor subtype, and signal of 
activation. Release of PGE2 is known to induce a TH2 – type of response with 
suppression of T cell proliferation as well as inhibition of IFN-γ secretion (63, 
64). In addition, it stimulates cytokine production by DCs, macrophages and B 
cells towards a TH2 response (65). Recent reports underscore the exploitation 
of PGE2 during Francisella infection of macrophages (66) and during S. 
pyogenes infection in vivo (65, 67). It appears that these bacteria can utilize 
PGE2 to facilitate infection by promoting an anti-inflammatory host response.  
 
 
1.1.3 Phagocytosis	  and	  other	  uptake	  mechanisms	  
There are multiple ways of pathogen uptake by phagocytes. In most cases, the 
primary interaction induces a signaling cascade, which results in 
rearrangement of the actin cytoskeleton and subsequent reformation of the 
plasma membrane to assist the procedure, Figure 3. Often, host cell integrins 
are involved in activation and modulation of the actin filaments via 
phosphorylation of cytoplasmic domains. Conventional phagocytosis is 
probably the most well-known uptake mechanism by cells. The discovery of the 
capacity of cells to engulf particles awarded Elie Metchnikoff the Nobel prize in 
1908. Since then this process has been investigated in detail and much 
progress has been made in understanding the molecular events underlying this 
procedure, which activates a variety of signaling cascades with their effector 
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functions (68). Several receptor-interactions induce phagocytosis such as 
binding of immunoglobulin to FcRs or complement proteins to CRs and binding 
of PAMPs to TLRs or scavenger receptors to mention a few. Often the same 
pathogen is recognized by several receptors inducing multiple signaling 
cascades with the final goal to eliminate the invader (69). Different mechanisms 
of phagocytosis with characteristic morphology have been described such as 
zippering, triggering and coiling phagocytosis. It is evident that the uptake 
mechanism differs depending on the prey, the host cell and which receptors are 
involved in recognition. The zippering pathway involves formation of a tight 
vacuole that surrounds the pathogen and transfers it into the cell. Listeria and 
Yersinia are both taken up via this pathway (70). The triggering/micropinocytic 
pathway is used for example by Salmonella and Shigella where the pathogens 
induce membrane ruffling by secreting factors into the host cells stimulating 
uptake in a spacious vacuole (71). Legionella is taken up by coiling 
phagocytosis, during which the host cell membrane forms long pseudopodia 
that tightly encircles the bacterium prior to entry (72).  
 
 
 
Figure 3. Simplified schematic illustration of various entry mechanisms.  
 
 
Furthermore, Francisella and S. pyogenes are taken up by yet another 
mechanism inducing formation of large asymmetric spacious pseudopod loops 
(73, 74). In addition, there is a mechanism called caveolae-mediated entry, 
which involves induction of invaginations in the plasma membrane, which 
morphologically differs from the other pathways, and has been shown to 
mediate uptake into host cells for several pathogens (75, 76).  
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1.2 STREPTOCOCCUS	  PYOGENES	  
	  
1.2.1 Disease	  spectrum	  
The Gram-positive Streptococcus pyogenes, also called β-hemolytic group A 
Streptococcus, is estimated to cause 500 000 deaths yearly, (Table 2) (77), 
rendering it number nine on a scale of worst infectious diseases world wide. It 
has a wide disease spectrum ranging from uncomplicated throat and skin 
infections to invasive life-threatening diseases with a mortality rate of up to 60% 
(78-80).  
 
Disease Number of existing 
cases 
No of new cases 
each year 
No of deaths 
per year 
Severe S. pyogenes 
diseases 
 
 
  
Rheumatic heart disease 16,24 million 460 000 349 000 
Acute post streptococcal 
glomerulonephritis 
N/A 472 000 5000 
Invasive S. pyogenes 
diseases 
- 663 000 163 000 
Total severe cases 18,1 million 1,78 million 517 000 
Superficial S. pyogenes 
diseases 
   
Pyoderma 111 million - - 
Pharyngitis - 616 million - 
 
Table 2. Number of S.pyogens cases world wide. Adapted from (77). 
	  
	  
1.2.1.1 Uncomplicated	  throat	  and	  skin	  infections	  	  
 
The majority of S. pyogenes infections are throat infections, which world wide 
account for an estimated 616 million cases each year (Table 1) (77). Most 
people come in contact with S. pyogenes in young age, resulting in 
tonsillitis/pharyngitis or impetigo that are easily treatable with penicillin. 
However, recurrent tonsillitis is relatively common, and it has been suggested 
to be associated with bacteria persisting inside epithelial cells of the tonsils, 
thus avoiding killing by penicillin (81). There are also high numbers of 
asymptomatic carriers in the population, especially among children. Pharyngitis 
is seasonal and more prevalent during fall and winter. S. pyogenes also cause 
skin infections such as erysipelas and impetigo/pyoderma, which are 
commonly more frequent during the warmer periods of the year. Erysipelas is 
characterized by a localized inflammation of the superficial layer of the skin 
whereas cellulitis affects the subcutaneous part of the skin and the soft tissue 
(82). Another infection caused by S. pyogenes is scarlet fever, which is usually 
associated with throat infections; but it can also arise from infections at other 
locations (83). 
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1.2.1.2 Post	  -­‐streptococcal	  sequelae	  
 
Pharyngitis can sometimes result in acute rheumatic fever (ARF), an 
autoimmune disease that is most common in the developing world where 
repeated throat infections, left untreated, can lead to this sequelae. In some 
cases ARF can progress into rheumatic heart disease (RHD), causing 
permanent heart valve damages and risk of death due to heart failure (84). 
Acute glomerulonephritis is a kidney inflammatory disease that can arise 
following streptococcal infections, most commonly after skin infections. 
Association between certain M types and pharyngeal or skin infections that 
coincided with outbreaks of ARF respectively glomerulonephritis led to the 
terminology rheumatogenic and nephritogenic types (85).  
 
 
1.2.1.3 	  Severe	  invasive	  infections	  
 
The infections described in the section above are non-severe and responding 
well to antibiotic therapy, if not progressing into the different sequeale 
described. Nonetheless, S. pyogenes may also give rise to severe invasive 
manifestations such as necrotizing fasciitis and streptococcal toxic shock 
syndrome (STSS). Although these infections are relatively rare, they represent 
a substantial health problem due to their high mortality and morbidity, which 
has given them the nickname “flesh-eating bacteria” commonly used by the lay 
press. Puerperal sepsis involving infection of the uterus that rapidly becomes 
systemic is also a severe manifestation that may be caused by S. pyogenes. 
This was a frequent cause of maternal deaths during the 1700 and 1800 
centuries (84).  Another severe state is streptococcal sepsis, which develop 
upon entry of S. pyogenes into the blood stream. This can occur through a 
wound, an insect bite or by transition through the tissue from an infection of the 
mucosa or epidermis. However, in 50% of the cases, the portal of entry is not 
known (86). S. pyogenes sepsis can rapidly progress into STSS, which is 
characterized by an enormous activation of the immune system mediated by 
bacterial toxins, so called superantigens, which are described in more detail in 
the pathogenesis section. This condition is associated with hypotensive shock 
and multiple organ failure early in the course of infection (83). The mortality rate 
is high, often exceeding 40%, despite prompt antibiotics in most cases. 
Necrotizing fasciitis is a rapidly advancing soft tissue infection characterized by 
fascial necrosis. Approximately 50% of the necrotizing fasciitis cases also 
develop STSS, which is associated with even higher mortality rates of up to 
60% (78-80). An important problem with these rapidly progressing infections is 
the difficulty to make the right diagnosis at admission to the hospital. This is 
due to often unclear general initial symptoms such as malaise, fever, flu-like 
symptoms and signs of soft-tissue infections like localized swelling, pain and 
erythema. A hallmark symptom is severe pain. Known risk factors include skin 
trauma, drug abuse, surgery, diabetes, varicella, and burns in addition to 
genetic predisposition and lack of type-specific antibodies (83, 87-89).  
 
During these severe invasive infections, patients are given intravenous 
antibiotics, commonly a β-lactam and clindamycin, and due to the heavy 
vascular leakage, massive amounts of intravenous fluids (86). Intravenous 
polyspecific immunoglobulin G (IVIG) has been suggested as an effective 
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additional therapy in STSS by virtue of its anti-inflammatory properties, as well 
as ability to neutralize superantigens and increasing the opsonizing effect in 
these patients with often very low antibody titers of streptococcal-specific 
antibodies (90-92).  
 
 
1.2.2 	  Epidemiology	  
S. pyogenes are most commonly characterized based on M-typing. The first 
method for serotyping was established in the 1920’s by Rebecca Lancefield 
(93). The M-protein is expressed on the bacterial surface and the typing 
method relies on variations in the aminoterminal part of the protein in different 
S. pyogenes strains. The M-proteins are extracted and then studied in a 
precipitin-based test with standardized M-type specific sera. However, there 
were several problems with this typing method, including difficulties in 
producing high titers of type-specific antisera, and the high numbers of non-
typeable strains. An alternative method is the opacity test. Approximately half of 
the S. pyogenes strains express the opacity factor, a lipoproteinase causing 
serum to increase in opacity. Antibodies against the opacity factor are type-
specific and correlate with the M-type (94, 95). Another test used to distinguish 
strains and to correlate specific strains to outbreaks is T-typing, which is based 
on an agglutination assay. The T-protein is also expressed on the bacterial 
membrane and T-antigens are often M-type specific, rendering them a good 
alternative when the M-protein is not identifiable (96). Today, typing is 
commonly done by emm-sequencing (97) and currently, there are more than 
150 different emm-types identified (98). These are all methods used in the 
research laboratory, however upon clinical diagnosis of patients, immune 
responses towards extracellular products such as streptolysin O (SLO), DNase 
B, hyaluronidase, NADase, and streptokinase may be included.  
 
A recent review of the distribution of the streptococcal M-types world wide 
revealed that there are large differences between the high-income countries, 
USA, Canada and Europe as compared to low-income countries in Africa and 
the Pacific (99). The data further showed variations in disease spectrum, where 
pharyngitis and invasive disease were the most prevalent causes of infection in 
the high-income countries in contrast to low-income countries where the post-
streptococcal sequelae, ARF, RHD and acute post-streptococcal 
glomerulonephritis are dominating. However, it should be noted that a major 
drawback is that there is a lack of data from most of the low-income countries 
making it difficult to get a conclusive analysis (99). 
 
 
1.2.3 Vaccine	  development	  
Vaccine development of S. pyogenes has been discussed for decades, and 
C5a peptidase and especially the M-protein have been proposed as interesting 
targets (100, 101). Only one vaccine has so far been processed for clinical 
trials. That is a 26-valent vaccine, intended to target the most predominantly 
occurring M-strains in the US (102). One concern with this vaccine, as 
highlighted in the review by Steer et al (103) is that the M-types included in the 
vaccine are not the same ones causing infections in low-income countries 
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where most of the deaths occur. Another major concern with serotype-based 
vaccines is the risk of serotype replacement in the society. This was seen after 
the introduction of a 7-valent pneumococcal vaccine towards invasive strains in 
the US, where the number of pneumococcal infections with the 7 serotypes 
included in the vaccine was reduced (104), whereas strains of other serotypes 
increased with 45% (105, 106). One way to overcome the serotype 
dependency is to create a vaccine with specificity towards the conserved part 
of the M-protein, which is identical in all strains. A difficulty with this vaccine 
design is cross-reactivity of epitopes in the conserved region with human 
myosin, which is expressed in heart-, brain- and joint tissues (85), see Figure 4.  
However, identification of these specific epitopes on the M-protein opened up 
possibilities to create peptides that avoid the cross-reactive parts of the protein 
(107). A new vaccine candidate of the conserved region was recently reported 
to induce a wide humoral and cellular response in proliferation assays of 
RF/RHD patients and healthy controls (108). Its efficiency during in vivo 
conditions remains to be shown.   
 
Figure 4. Schematic picture of the M1-protein with the hyper-specific and cross-reactive 
regions indicated. 
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1.2.4 Pathogenesis/virulence	  factors	  
S. pyogenes has a wide disease spectrum, causing infections in many different 
locations and with varying severity. It has a large array of bacterial factors 
enabling this versatile behavior and rendering the bacteria easily adaptable to 
the current surroundings. Several strains have become associated with 
different diseases. This is evident by the association of specific types with 
particular disease manifestations, such as the association of M1 and M3 strains 
with outbreaks of STSS and necrotizing fasciitis and M28 with puerperal sepsis. 
 
In general, around 10% of the genome of sequenced strains consists of genetic 
mobile elements such as prophages and prophage-like elements, which 
accounts for most of the heterogeneity among the strains (109). The clinical 
significance of differential genome sequence has been underscored in several 
studies. Sequencing of 114 isolates of M28 serotype revealed a new genetic 
element, not previously found in other sequenced S. pyogenes strains but is 
related to regions in Streptococcus agalactiae (Group B streptococcus), a 
pathogen important in neonatal infections (110). One of the proteins encoded 
by this genetic element, R28, was subsequently shown to bind to vaginal 
epithelial cells in vitro and suggested to facilitate the colonization of the female 
genital tract (110, 111). Another example is the invasive M1 clone that has 
been studied in the papers of this thesis (112) and the M3 serotype, both of 
which have been associated with severe invasive diseases (113-116). 
Comparisons of their genome sequences and that of other serotypes reveled 
that the M1 and M3 have a specific set of phage-encoded genes. For example, 
new phage-encoded variants of SpeA were found upon sequencing of 
contemporary strains of M1 and M3 serotype, and it has been speculated that 
these phage-encoded genes contribute to the increase in severity in these 
strains (117, 118).   
 
 
1.2.4.1 Adhesion	  
 
S. pyogenes express various cell-surface proteins, which enable binding to 
host cells.  Recently a pili-like structure was identified and shown to be involved 
in bacterial epithelial cell adherence and biofilm formation (119-121). Also 
lipoteichoic actid (LTA) and C5a peptidase have been reported to have 
adhesive roles. In addition to its adhesive properties, C5a peptidase cleaves 
the complement component C5a (122, 123). However the most well described 
adhesins are the fibronectin binding proteins  (FnBPs). Protein F1 (PrtF1/Sfbl) 
is essential for Fn-mediated adherence (124, 125) and it can also interfere with 
the complement system through inhibition of C3 deposition on the bacterial 
surface, thereby avoiding phagocytosis (126). It has also been shown to 
mediate invasion into host cells (127).  Nevertheless, it is not expressed by all 
strains, some strains lacking PrtF1 express PrtF2 instead, a protein critical for 
adherence of M49 to epithelial cells. Interestingly, the M1 strains lack both of 
the proteins but encode FbaA, another protein involved in adherence to 
epithelial cells (128). The M3 and M18 serotypes encode FbaB, which also has 
specificity for fibronectin and mediates adhesion to epithelial cells (129). In 
addition, the M3 serotype have a bacteriophage encoding a phospholipase A2 
(SlaA) that has been reported to contribute to bacterial adhesion of pharyngeal 
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epithelium (130). In summary, there is a complex interplay and many factors 
are involved in the process of bacterial adhesion to host cells. It has been 
proposed that the hydrophobic interactions of the LTA initiates contact between 
the bacteria and the host cell allowing other adhesins such as the PrtF1 to form 
high-affinity interactions (131).  
 
 
1.2.4.2 M-­‐protein	  
 
The M protein is a classical virulence determinant of S. pyogenes. It is 
composed of two polypeptide chains in an alpha-helical coiled-coil composition 
that forms fibrils on the bacterial surface. In addition to the surface location, it 
can be shedded by enzymatical activity, excerted by bacterial or host cell 
proteases (132, 133). M-protein possesses anti-phagocytic activity, which is 
achieved via interference with the complement system and inhibition of 
complement opsonization (134-136).  Studies of the adhesive effect of M-
protein have reported some opposing results. For example, M protein can bind 
to Hep-2 epithelial cells and keratinocytes but not to buccal or tonsillar epithelial 
cells (137, 138). Both M-protein and PrfF1 have been shown to be differentially 
regulated by changes in the atmosphere with PrtF1 being expressed when the 
O2-level is increased, whereas M-protein at higher CO2 (139). It has been 
proposed that during infections of the epidermis (higher O2), PrtF1 is expressed 
and mediates binding to cutaneous surfaces, while in the deeper tissue M 
protein is expressed and mediates binding to keratinocytes (140). This is also 
the case during infection of respiratory epithelial cells, where the oxygen level 
regulates expression of virulence factors important for adherence and invasion 
into the tissue (141).  
 
Recent reports have highlighted the inflammatory properties of the M-protein as 
summarized by Oehmcke et al. (142). A major finding was that shedded M-
protein was a powerful inducer of vascular leakage (133), which is one of the 
most prominent complications associated with severe streptococcal infection. In 
addition, M-protein has proven to act as a superantigen activating a massive T 
cell response (143), and also to interact with monocytes via TLR2 resulting in 
their production of interleukin 6 (IL-6), tumor necrosis factor alpha (TNF-α) and 
IL-1β (144). 
 
 
1.2.4.3 Extracellular	  products	  
 
A hallmark of the invasive diseases is major tissue destruction and systemic 
toxicity (82), which is to a large extent due to secreted factors, including 
different bacterial enzymes and exotoxins. Two well-characterized haemolysins 
are SLO and Streptolysin S (SLS). SLO is a pore forming lysin, which is toxic to 
PMNs and platelets in addition to erythrocytes. Moreover, it has been shown to 
prevent degradation of S. pyogenes in pharyngeal epithelial cells by disrupting 
lysosomes and thereby avoiding a pH-dependent destruction (145). Recently it 
has also been proven to have a role in dissemination of bacteria from infected 
phagocytic cells by inducing cell death (146, 147). SLS is produced upon 
contact with serum and it is one of the most potent cytotoxins known, affecting 
PMNs, platelets and sub-cellular organelles. Recently, SLS was shown to 
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facilitate invasion into deeper tissues by degradation of epithelial intercellular 
junctions (148). Other factors enabling spread from one tissue layer to another 
include secreted DNAses (DNase A, B, C, D and Sda1), hyaluronidase, which 
degrades hyaluronic acid present in the connective tissue and streptokinase 
(SKA), which acts to promote dissolving of clots (137). Streptococcal exotoxin 
B (SpeB) is a potent cysteine protease, with many substrates such as human 
extracellular matrix, immunoglobulins, complement components, IL-1β and the 
antimicrobial peptide LL-37 (149). However, SpeB can also cleave endogenous 
substrates, which demands a tight regulation of the gene expression (149).  
Streptococcal inhibitor of complement (SIC), a secreted protein produced by 
only a few serotypes including M1 strains, can bind to the insertion site of 
complement proteins inhibiting phagocytosis of the bacteria as well as 
inactivating antimicrobial peptides (150, 151).  GRAB (G-related α-2-
macroglobulin-binding protein), is a membrane bound protein that binds α-2-
macroglobulin, a highly abundant proteinase inhibitor found in human plasma. 
Binding of α-2-macroglobulin to the bacterial surface via GRAB lead to 
entrapment of SpeB at the bacterial surface, and consequently renders the 
bacteria protected from SpeB-mediated degradation of virulence factors (152). 
Furthermore, this complex protects against the antimicrobial peptide LL-37, as 
these small peptides enter the complex and are degraded by SpeB (153). A 
recently described virulence factor is the S. pyogenes cell envelope proteinase 
(SpyCEP), which has also been shown to impede the host response by 
inactivating chemotactic signals, in particular IL-8 (154, 155).  
 
 
1.2.4.4 Pyrogenic	  exotoxins	  
 
The streptococcal pyrogenic (fever producing) exotoxins are central mediators 
of STSS and necrotizing fasciitis. They consist of the phage-encoded SpeA 
and SpeC, as well as chromosomally encoded SpeG, SpeH, SpeJ, SpeK, 
SpeL, SSA, SMEZ and SMEZ-2. They all have superantigen activity inducing a 
massive immune activation, which results in liberation of large amounts of 
inflammatory cytokines including among others TNF and IFN-γ (156, 157). 
Bacterial superantigens are characterized by their ability to bind intact, without 
prior cellular processing, to the outer part of the MHC class II-molecule and the 
T cell receptor (TCR) (Figure 5). Binding occurs to a subset of T cells bearing 
specific Vβ sequences in their TCR, thereby activating 20-30% of the entire 
resting T cell population (158, 159) which leads to a massive cytokine storm. 
This excessive immune activation results in the systemic toxicity associated 
with STSS (86). 
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Figure 5. Schematic figure of the MHC II-TCR interaction with a superantigen bound to the 
outer part of the complex. 
 
 
1.2.5 Regulation	  of	  virulence	  factors	  
The pathogenesis of severe invasive diseases is complex and involves an 
array of bacterial components that contribute to initial adherence/colonization, 
invasion and modulation of immune responses. It is a complex scenario with 
many players involved. In the following section bacterial regulation of virulence 
factors is discussed. 
 
	  
1.2.5.1 Two	  component	  systems	  	  
 
S. pyogenes regulate its own gene expression in a sophisticated way in order 
to adapt to the environment during infection. The bacteria express a number of 
virulence factors during the process and different factors are expressed 
depending on the stage of infection. These proteins are regulated through 
distinct mechanisms where stand alone regulators (160) and two component 
systems (TCS) (161) are the principal types. Through genome sequencing it 
has been estimated that S. pyogenes have approximately 100 response 
regulator homologs. Out of these, 13 belong to the TCS, which normally consist 
of two parts, a sensory and a regulatory component (161). The sensor 
component is typically a transmembrane protein with an extracellular sensor 
histidine kinase that recognizes one or more specific environmental signal(s). 
Examples of such signals include changes in ion concentration, osmotic 
pressure or pH. Upon sensing the activation signal, the histidine kinase is 
activated and a phosphoryl group is transferred to the response regulator (RR). 
The RR is cytoplasmic and the majority of them are transcription factors with 
DNA binding domains that act by repressing or activating transcription of 
specific genes upon phosphorylation (161, 162). In S. pyogenes 4 TCSs have 
been studied in more detail, i. e. CovR/S, FasBCAX, SptR/S and Ihk/irr. The 
CovR/S is in control of many of the virulence factors and is described below. 
FasBCAX has homology to quorum sensing systems in Staphylococcus aureus 
and Streptococcus pneumoniae, and it has been shown to regulate adhesins, 
such as fibronectin/fibrinogen binding proteins as well as hemolytic activity and 
streptokinase transcription in a growth phase dependent manner (163). SptR/S 
was recently shown to be important for S. pyogenes persistence in human 
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saliva (164). Ihk/Irr activation has been shown to be induced upon encounter of 
blood cells, and it is involved in resistance to phagocytic degradation in 
neutrophils (165, 166). Recently, a new TCS, TrxSR was identified and found 
to be repressed by CovR. It is the first TCS shown to regulate Mga expression, 
described later in this section (167). 
 
 
1.2.5.2 CovR/S	  
 
The best characterized TCS in S. pyogenes is the CovR/S (168), control of 
virulence, formerly named CsrR/S for capsule synthesis regulator. The name 
was changed when the system was found to regulate also other genes than 
those involved in capsule synthesis (169), including the hyaluronic capsule, 
SKA, SLS, SpeB, and Mac-1–like protein (Mac)/Immunoglobulin G-degrading 
enzyme of S. pyogenes (IdeS). The CovR/S system acts primarily by 
repressing transcription of the genes that it regulates (169, 170). However, 
when S. pyogenes encounters stress, such as during infection, CovS acts by 
de-phosphorylating CovR enabling transcription of the repressed genes that 
are needed for invasion (171). Colonies of CovR mutants are for example 
mucoid due to the expression of the capsule gene leading to an increased 
production of hyaluronic acid (171). CovR/S regulation affects approximately 
15% of the bacterial genome of which many encoded genes are virulence 
factors (172).   
 
In a murine model of skin and soft tissue infections; a transition from non-
invasive to invasive phenotype was noted during disease progression after 
infection with a M1T1 strain (173). Sequencing of isolates from these infections 
revealed a mutation in the covS gene, resulting in decreased expression of 
SpeB, which is positively regulated by CovS. This renders the bacteria more 
virulent by higher expression of virulence factors that would otherwise be 
degraded by SpeB. Also microarray comparisons of bacteria from pharyngeal 
and invasive murine infections revealed mutations in covR/S (174). However, 
covS seems to have a very distinct way of fine-tuning gene expression of CovR 
repressed genes as reported by Treviño et al. (175). Some early studies on 
clinical isolates from severe and non-severe infections indicated an inverse 
relationship between SpeB expression and disease severity (176). Recently 
there have been reports of human isolates of invasive infections with this 
mutation in the CovR/S regulatory system indicating that this also happens 
during infection in the natural host (177).  Interestingly, in a recent case-report, 
two isolates were taken from the same patient, one from the blood and one 
from the pharynges. When sequencing the strains, the sole difference was a 
mutation in the covS gene of the blood isolate, rendering it invasive and 
enabling the progression into the blood stream (178). However, analyses from 
tissue biopsies of patients with necrotizing fasciitis revealed high levels of SpeB 
at the tissue site of S. pyogenes infection (179); thus, underscoring the fine 
tuned expression of virulence factors at different sites and stages of infection.  
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1.2.5.3 Ihk/Irr	  
 
The Ihk/Irr TCS was identified by Federle et al, who were studying regulation of 
virulence factors and especially systems with homology to the PhoP-PhoS TCS 
in Bacillus subtilis (169). The PhoPS system is widely distributed among 
bacterial species and is involved in regulating virulence factors through sensing 
of the phosphate concentration in the surrounding environment (180).  The Pho 
sensing subunit is located in the inner membrane and is interacting with an 
ATP-binding cassette (ABC) type phosphate-specific transport system that 
during low phosphate conditions activated the regulatory unit leading to up- or 
down regulation of the affected gene (180). ABC transporters are important 
components for bacterial metabolism as they import and export for example 
nutrients and ions for different purposes, such as virulence and general 
nutrition. Iron acquisition through iron ABC uptake systems is an example of a 
process designated to bacterial virulence. Specific iron-binding proteins, such 
as transferrins and lactoferrins, are transported through the system, and iron is 
extracted from these by the bacteria (181).  
 
It has been shown that ihk/irr is highly up-regulated during infection of human 
PMNs (182), macrophages (Paper II), in whole blood and in saliva (164, 166). 
Importantly, studies in human PMNs as well as in mice infected with wild type 
or an ihk/irr mutant revealed an important role of this TCS in resistance to ROS 
during infection (165).  Another regulatory system that has been involved in 
resistance to ROS is PerR, peroxide stress response regulator (183). PerR was 
recently shown to be important for resistance to oxidative burst of S. pyogenes 
in human whole blood as well as for bacterial survival in a baboon model of 
pharyngitis (184). PerR is also found in Bacillus subtilis and Staphylococcus 
aureus, where it is known to regulate peroxidases, such as catalase and 
alkylhydroperoxide reductase, in addition to coordination of the oxidative stress 
responses and iron metabolism in these species (185, 186). S. pyogenes do 
not express catalase, which other Gram-positive bacteria use to degrade H2O2 
to H2O and O2, but instead it has several alternative peroxidases such as alkyl 
hydroperoxidase, glutathione peroxidase and NADH peroxidase. These have 
been shown to be important for ROS detoxification both in vitro during different 
O2 conditions and in in vivo infections of murine model systems (183, 187-189). 
 
 
1.2.5.4 Stand-­‐alone	  regulators	  
 
Stand-alone regulators are transcriptional regulators that are primarily involved 
in adaptation to the host environment during infection and regulate for example 
carbohydrate utilization and metabolism (190). Their activation signals and 
sensory elements remain unknown (162). The three most defined regulators 
are the multiple gene regulator (mga), the RofA-like protein family (RALPs) and 
the Rgg/RopB. They have basically been divided into different functional 
expression periods during infection, where the mga regulates genes involved 
during adherence and colonization, the RALPs co-ordinate gene expression 
during the internalization and persistent phase and the RopB/Rgg system 
regulate genes involved during dissemination, as reviewed in (160).  The TCSs 
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act to fine-tune the events described above by their ability to sense the 
surroundings (162). Gene regulators also regulate each other during the 
infection process. One example is the Rgg that repress both mga and CovR/S, 
while ihk/irr on the other hand is down-regulated following Rgg inactivation 
(191). At the same time expression of SpeB can repress Rgg (192).  
 
In general it is believed that during the initial phase of streptococcal infection, 
Mga is upregulated and also the Ihk/Irr system, resulting in increased amounts 
of adhesins, such as fibronecting-binding proteins, M and M-like proteins, that 
are important for adherence and invasion into host cells and tissues as 
reviewed in (160). During the second stage, both CovR/S and RALPs are 
active; there is a bacterial replication ongoing, repair of oxidative damage and 
high protein turnover. During dissemination, it has been suggested that Rgg is 
expressed whereas the mga regulon remains suppressed and the speB, slo, 
speG, grab genes are transcribed resulting in spread of infection by increased 
enzymatic activity (160), see Figure 6.  
 
Figure 6. General characteristics of gene regulation during S. pyogenes infection. Adapted 
from (160). 
 
 
A temperature study designed to mimic the different conditions during infection 
in skin, throat and deep tissue revealed that 9% of the genome was altered 
between 29ºC to 37ºC (193). Especially genes encoding secreted proteins, 
such as hemolysins and proteins, involved in iron homeostasis, were shown to 
be temperature-dependent. Many metabolic enzymes involved in glycolysis 
and fatty acid metabolism were down-regulated at 29ºC as well as virulence 
regulator RofA. Instead genes encoding proteins involved in iron homeostasis 
were up-regulated at 29ºC. At 40ºC, the ferric uptake repressor, Fur, was 
down-regulated, indicating the need for iron during fever. During infection of the 
throat, the bacteria come in contact with saliva. Microarray studies of in vitro 
growth of S. pyogenes in human saliva revealed a new TCS, the SptR/S, which 
is essential for bacterial persistence in this type of environment. SptR/S is 
positively regulating a number of virulence factors such as DNases, SpeB, the 
hyalyronic acid capsule and genes encoding carbohydrate transporters.  During 
early infection, genes encoding proteins involved in adherence and resistance 
to the host such as M-protein and SIC as well as oxidative stress responses, 
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ATP generation and pH-balance, were up-regulated. However as the infection 
proceeds metabolic genes and virulence factors such as DNases and 
pyorgenic enzymes as well as stress-response regulators were most active 
(164). Infection of human blood almost alters a third of the bacterial genome. 
Here, also M-protein and SIC are up-regulated, as well as the regulatory 
systems; mga, rofA and Ihk/Irr and as infection progresses, transcription of 
covR/S increases (166).  A study of the carbohydrate regulator, catabolite 
control protein A, showed that growth of a mutant strain was dependent of the 
media. Reproduction in human saliva was heavily affected while growth in rich 
cell culture media did not affect reproduction significantly, indicating the 
importance of carbohydrate regulation for replication and virulence (194). 
	  
	  
1.2.6 S.	  pyogenes	  as	  an	  intracellular	  pathogen	  
Traditionally S. pyogenes has been considered as an extracellular pathogen. 
The first evidence of intracellular S. pyogenes was published in the mid 1990’s. 
Following pharyngitis infection, intracellular bacteria have been found in the 
epithelial cells lining the mucosa (81). In in vitro models, invasion and survival 
of bacteria has been shown in epithelial (195, 196) and endothelial cells (197). 
In patients, formation of an intracellular reservoir, protecting from penicillin 
treatment, has been proposed to contribute to treatment failure and recurrent 
tonsillitis (81). In addition, investigations of biopsies from patients with severe 
streptococcal tissue infections revealed viable bacteria inside macrophages 
despite prolonged antibiotic therapy (179). This was the first evidence of S. 
pyogenes inside professional phagocytes during human infection. In addition, 
persistence inside macrophages has been confirmed in vitro (179). S. 
pyogenes has also been shown to circumvent degradation in PMNs through 
avoidance of azurophilic fusion with the phagosome (198-200). Various 
internalization mechanisms have been reported for different host cells as 
shown in table 3. These mechanisms were discussed in section 1. 1. 3, 
delineating uptake mechanisms by host cells.  
 
 
Cell	  type	   Mechanism	   M-­‐type	   Reference	  
Epithelial	  cells	   Caveolae	  
Zipper-­‐like,actin-­‐dependent	  
M12	  
M1	  
Rohde	  et	  al.	  (75)	  
Dombek	  et	  al.	  (201)	  
Endothelial	  cells	   Zipper-­‐like,	  actin-­‐dependent	  
Caveolae	  
M3	  
	  
M12	  
Nerlich	  et	  al.	  (202)	  
	  
Rohde	  et	  al.	  (75)	  
Macrophages	   Phagocytosis,	  	  
actin-­‐dependent	  
M1	   Paper	  I	  
PMNs	   Phagocytosis,	  	  
actin-­‐dependent	  
M1	   Staali	  et	  al.	  (199)	  
 
Table 3. Entry pathways of S. pyogenes into various human host cells.  
 
 
It has been shown that M1 S. pyogenes are able to induce up-regulation of 
integrin expression on epithelial cells and thereby promote uptake (203). Upon 
invasion of M12 S. pyogenes into endothelial and epithelial cells, intracellular 
bacteria can reside in caveosomes and avoid the endosomal-lysosomal 
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degradation pathway as there is no co-localisation of the different markers of 
the forming phagolysosome and the pathogens (75). In keratinocytes, S. 
pyogens has been reported to circumvent phagolysosomal destruction through 
secretion of SLO, which has been shown to act in the same manner as the 
pore-forming toxin, listeriolysin O of Listeria species, and thereby enable 
bacterial escape from the phagosome (145, 204). In PMNs the M1-protein 
inhibits azurophilic fusion with the phagosome (198).  In macrophages, S. 
pyogenes associate with the early endosomes but not with the late endosomes 
or lysosomes and as in PMNs, the avoidance of phagosomal maturation is 
dependent on expression of M1-protein (Paper I). Studies of intracellular S. 
pyogenes in human epithelial cells have reported a caspase 9-dependent 
induction of apoptosis upon infection (205, 206).  In another study using 
epithelial cells, S. pyogenes were shown to ultimately be degraded via 
autophagy after SLO-induced phagosomal escape into the cytosol (204). The 
autophagy compartment was characterized by expression of LC3 and Rab7 
(207). Cell death has also been reported during infection in macrophages, 
however the mechanism is still debated since SLO was suggested to induce 
caspase-1 associated pyroptosis in one study (147) and apoptosis in another 
(146). In summary, there are many different mechanisms described and 
despite intense research during the past two decades there are still many 
aspects that remain unknown. 
 
Next section comprises an introduction to the interactions between the host and 
bacteria, focusing on traditional intracellular pathogens and their survival 
strategies.   
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1.3 HOST-­‐PATHOGEN	  INTERACTIONS	  
1.3.1 Survival	  mechanisms	  of	  intracellular	  bacteria	  
As cells and pathogens have lived side by side through millions of years, 
several microbes have evolved systems to circumvent their destruction by the 
immune system. A number of pathogens have created systems to avoid 
intracellular degradation (208-210) and some have even generated ways to 
form a safe environment within the host, aimed for intracellular replication 
(211). These are so-called professional intracellular bacteria. Entry into host 
cells is gained via different mechanisms. Many involve activation of a signaling 
cascade that induces rearrangement of the actin cytoskeleton and formation of 
membrane protrusions enabling bacterial uptake. Below is a table containing 
uptake mechanisms of selected intracellular bacteria into macrophages or 
epithelial cells. Next section comprises an introduction to bacterial survival 
strategies.  
 
 
Pathogen Mechanism  Cell type Reference 
Listeria Zipper – actin dependent – via 
CR 
Epithelial (70) 
Shigella Trigger – actin dependent -“- (70) 
Salmonella -“- -“- (70) 
Legionella Phagocytosis – via CR Macrophage (212), (213) 
Francisella -“- -“- (73) 
Mycobacterium Phagocytosis- various 
receptors 
-“- (213) 
Coxiella Phagocytosis - αvβ3 integrin -“- (214), (213) 
Yersinia Zipper – actin dependent Epithelial (70) 
 
Table 4. Entry mechanisms of various professional intracellular bacteria into host cells. 
 
 
1.3.1.1   Manipulation	  of	  cellular	  signaling	  and	  effector	  functions	  
 
One of the most well known intracellular pathogens is Mycobacterium 
tuberculosis. It can avoid phagosomal degradation and stay dormant in lung 
granulomas for long periods of time. It has a large array of mechanisms to 
prevent destruction through manipulation of the host cell response. One 
important immune response towards M. tuberculosis is activation of CD4+ T 
cells and their subsequent release of TNF-α and IFN-γ, which in turn induce a 
pro-inflammatory response and activation of macrophages and DCs. However, 
M. tuberculosis interfere with IFN-γ and NF-κB signaling through secretion of 
ESAT-6, which inhibits activation downstream of TLR-2 and subsequent 
induction of pro-inflammatory responses (215). Upon recognition of microbial 
products, the inflammasome is activated through caspase-1 activation with 
subsequent IL-1β secretion in the host cell. Inhibition of caspase-1 activation 
has been demonstrated to be mediated by factors expressed by 
Mycobacterium and Yersinia (216, 217). In addition, Mycobacterium can induce 
IL-10 secretion, which promote bacterial replication (218). IL-10 levels are also 
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high during chronic infection of C. burnetii promoting the M2 macrophage 
phenotype, which is poorly bactericidal (219). Recently, Shigella was shown to 
prevent phosphorylation of a specific subset of NF-κB-regulated genes 
encoding chemokines, including the important IL-8, thereby reducing infiltration 
of PMNs to the infection site. Other species that interfere with NF-κB signaling 
are Salmonella and Yersinia (220). Some species have developed 
mechanisms to circumvent oxygen radicals. Salmonella express superoxide 
dismutases that detoxify ROS secreted by the host cell (221) and like 
Mycobacterium and Legionella it detoxifies peroxynitrite to nitrite to inhibit 
oxidation of bacterial DNA (222). Yet another way to limit host response is 
utilized by Francisella that is able to alter its LPS structure, resulting in a 
compound that is a less potent activator of iNOS (223). This mechanism of 
antigenic variation to reduce immune recognition is also utilized by Salmonella 
and Mycobacterium (224).   
 
 
1.3.1.2  Manipulation	  of	  intracellular	  trafficking	  
 
Many intracellular bacteria have evolved mechanisms to interfere with the 
endosomal-lysosomal degradation pathway. There are basically three different 
mechanisms. The first is to inhibit maturation of the phagosome at some stage 
before fusion to the lysosome, second to escape from the phagosome before it 
starts to mature or finally to adapt to the phagosomal compartment (222), see 
Table 5. M. tuberculosis-containing phagosomes associate with the early 
endosomal markers, but it prevents further fusion and acidification with the late 
endosomal marker Rab 7 (225). In contrast, C. burnetti is contained in a 
vacuole that is acidified. It associates initially with EEA-1 and later with LAMP-
1, CD63 and M6PR and interestingly, bacterial viability is not affected by the 
low pH. The mechanism behind the avoidance of lysosomal fusion and 
degradation is suggested to be inhibition of Rab7-recruitment to the 
phagosome (219). 
 
 
Pathogen Mechanism to 
avoid degradtaion 
Vacuole markers Replicate in 
vacuole 
Reference 
Listeria Escape phagosome -, LAMP-1 - (213) 
Shigella -“- - - (70) 
Rickettsia -“- - - (70) 
Salmonella Avoid maturation to 
lysosome 
Phalloidin, ER + (222) 
Legionella -“- Rab1 + (213) 
Francisella -“- EEA-1, LAMP-1/2, 
Rab7 
- (40) 
Mycobacterium -“- Rab5 + (222) 
Coxiella Adapt to lysosome EEA-1, LAMP-1, 
CD63, M6RP, LC3 
+ (219) 
 
Table 5. Mechanisms to manipulate endosomal-lysosomal degradation and markers associated 
with the phagosomal compartment of selected professional intracellular species. 
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Salmonella has yet another way of forming a compartment that accumulates 
markers of the endoplasmic reticulum as well as proteins from both early and 
late endosomes and finally from the trans-golgi network (226). Intracellular 
Francisella are contained within a vesicle that recruits EEA-1, followed by 
Lamp-1, Lamp-2 and Rab 7 (40). This vesicle bursts upon acquisition of the 
vATPase pump, which induces the escape mechanism into the cytoplasm 
where replication occurs (227, 228). Similarly, acidification of the phagosome is 
a mechanism that also has been shown to induce burst of the Listeria-
containing phagosome (229). In addition, increase of Ca2+, which is required for 
fusion of endosomes and/or lysosomes, is inhibited by Mycobacterium and 
Listeria through interference in signaling of vesicle trafficking and perforation of 
the phagosome respectively (229, 230). 
 
Other bacterial species, such as Listeria, Shigella and Rickettsia, escape from 
the phagosomal compartment to the cytoplasm in order to avoid degradation. 
Listeria expresses listeriolysin O (LLO), by which it forms pores in the vesicle 
membrane and escape into the cytosol. This can occur as early as five minutes 
after infection and is followed by replication (39). However, it has recently been 
shown that during circumstances of low LLO levels, Listeria stay in the 
phagosome where it replicates slowly. The Listeria-containing phagosome 
acquires LAMP-1 positivity but it does not degrade the bacteria and this 
persistence has been suggested to contribute to chronic infection (231).  
Shigella escape the phagosome through secretion of lytic virulence factors 
(232) via its type three secretion system (T3SS), described below. Replication 
is initiated upon entry to the cytosol and autophagy is circumvented by factors 
processed by the T3SS (71). Interestingly, all three species posses the 
capacity to use host cell actin as a means of motility to promote intracellular 
and intercellular dissemination (233). Table 5 presents an overview of the 
proteins associated with the bacteria-containing vacuoles.  
 
Many Gram-negative bacteria have T3SSs, which are machineries forming a 
cylindrical needle-like organelle enabling transport of bacterial proteins into the 
host cell, facilitating pathogenesis (234). Studies of Salmonella pathogenicity 
island 2 (SPI-2) have revealed a T3SS encoding machinery that delivers 
factors into the vacuole inhibiting lysosomal fusion and oxidative stress as well 
as inhibition of NADPH oxidase fusion with the phagosome (235-237). These 
are all functions which are important for intracellular survival (210). Legionella 
encode a T4SS with which it can modulate the maturation process of the 
phagosome avoiding the endosomal-lysosmal pathway. Rab1 is recruited and it 
directs trafficking of ER-vesicles to the Legionella-containing phagosome (238). 
Ultimately, Legionella replicates inside a large vacuole with some properties of 
a phagolysosome before the host cell is lysed to release bacteria to the 
surroundings (239). Replication within a vacuole requires material to maintain 
the integrity of the membrane and to produce progeny. In Legionella, a 
machinery has been located to transfer substrate across the target host cell 
membrane to the replicating vacuole (240). In Salmonella SPI-2, SifA has been 
implicated in maintaining the replication vacuole, as mutants fail to keep the 
integrity of the vesicle resulting in bacteria in the cytosol (233).   
 
	  
  26 
2 AIMS	  OF	  THE	  THESIS	  
	  
This project was initiated upon finding viable bacteria in tissue macrophages of 
patients with severe S. pyogenes infections. The intracellular bacterial reservoir 
was linked to prolonged bacterial persistence at the tissue site. It was therefore 
of interest to investigate how the bacteria could survive within these 
professional phagocytes that has evolved only for the specific purpose of 
degrading invading microbes. Hence, the overall aim of the thesis was to 
decipher streptococcal survival strategies in macrophages. The specific aims 
were the following: 
 
1) To study bacterial entry and intracellular trafficking of S. pyogenes in human 
macrophages (Paper I). 
 
2) To investigate survival, replication and dissemination strategies of S. 
pyogenes in human macrophages. (Paper I). 
 
3) To analyze bacterial gene expression of intracellular S. pyogenes in 
macrophages and relate this to extracellular bacteria in order to identify 
factors supporting intracellular survival (Paper II). 
 
4) To investigate the functional aspects of gene regulation during intracellular 
survival and dissemination of S. pyogenes from human macrophages. 
(Paper II).  
 
5) To study host-response mechanisms to intracellular S. pyogenes with focus 
on Prostaglandin E2 (Paper III).   
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3 COMMENTS	  ON	  METHODOLOGY	  
	  
Detailed descriptions of the experimental procedures are found in the papers 
on which the thesis is based. In this section I will discuss advantages and 
disadvantages with methods and explain the rationale for choice of methods. 
 
 
In vitro infection assays 
As S. pyogenes is a human-specific pathogen, the studies are focused mainly 
on human cells. Investigation of soft tissue from patients with severe S. 
pyogenes infections revealed macrophages as the main host cell of bacteria. 
For that reason, we have developed an in vitro assay with primary human 
monocyte-derived macrophages (hMDM) using cells isolated from buffy coats 
from healthy donors. Naturally, there are limitations working with primary cells 
such as to number of cells per donor, inter-donor variations, availability of cells, 
time to prepare and maintain the cells. However, we have found that the 
positive aspects of working with primary cells overcome the drawbacks, 
including the fact that they mimic our findings in patients. During the years, we 
have also assessed different human monocytic cell lines, such as THP-1 and 
U937, in order to complement work with primary cells. However, these cells 
differed in several important aspects as compared to primary cells. Both THP-1 
and U937 have to be transformed in order to differentiate into macrophages, 
but even in the differentiated state, they did not adhere in the same manner as 
the primary cells. In addition, the morphology and the intracellular granularity of 
the cells were different as well as the infection efficiency. In conclusion, our 
experience with these cell lines is that they are not comparable to primary cells 
in our experimental set-up.  
One limit with the primary hMDM is its questionable oxidative stress responses. 
However, this problem has also been reported for human monocytic cell lines 
such as THP-1 (241) and may be a general aspect when working with human 
macrophages.  
 
 
In vivo infection assays 
Despite S. pyogenes being a human pathogen, there are animal models that 
are useful when studying specific aspects of infection in vivo. In this thesis, a 
murine model was used in collaboration with another research group working 
with murine S. pyogenes infection.  
 
 
Bacterial strains 
All in vitro infections have been carried out with a clinical M1T1 STSS isolate, 
5448, of S. pyogenes (89). This strain is well characterized in the group and is 
widely used in the field. An advantage using clinical strains is the preserved 
virulence in contrast to lab strains, which tend to loose virulence when adapting 
to rich media and lack of threat.   
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Generation of GFP-expressing bacteria 
To facilitate	   visualization of S. pyogenes during intracellular infection and 
trafficking, we created GFP-expressing bacteria using the clinical isolate. 
Incorporation of GFP enabled monitoring of both viability and location in 
relation to other fluorescent markers during infection, both with fixed samples 
and during live cell imaging. One aspect of GFP-expression is that it can be 
quenched by low pH. However, being aware of that risk, we have throughout 
the project kept monitoring bacterial DNA in addition to GFP-expression, to 
ensure visualization of GFP-negative cocci.  
	  	  
	  
Fluorescence and light microscopy 
Microscopy-based methods have been very useful tools during the course of 
these thesis projects. It has enabled visualization of the bacterial behavior 
during infection and its association/lack of association with different 
compartments as the infection progress. Antibodies specific for proteins 
expressed during the different stages of phagosomal maturation were used to 
visualize the endosomal-lysosomal degradation pathway. Although microscopy 
can be used to quantify expression in combination with appropriate software, 
this is often more easily achieved by other methods such as flow cytometry 
described below.  
 
 
Electron microscopy 
Electron microscopy was something that we decided to use to study the uptake 
mechanism as well as the interaction of intracellular bacteria with vacuoles. 
This method enables visualization of structural details of the plasma membrane 
as well as the organelles within the host cell at very high magnification.   
 
 
Flow cytometry 
Flow cytometry is a useful quantitative method. It enables measurements of 
various cellular characteristics through sorting on size, granularity and binding 
to various fluorescent antibodies. We used it to measure uptake of bacteria in 
different settings as well as to study differentiation markers on macrophages.  
 
 
Western Blot 
Western blot was used to investigate phosphorylation of activation molecules. It 
is a classic method to study proteins. Nowadays phosphoflow is emerging as a 
very useful tool to look at phosphorylation.  
 
 
PCR and quantitative real-time PCR 
PCR was used to reverse-transcribe RNA to cDNA. Quantitative real-time PCR 
was used to verify the gene expression seen in the microarray analysis. The 
advantage with the real-time compared to the conventional PCR is that it allows 
for quantification of the gene, which enables comparison of gene expression 
between different genes.  
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Microarray 
Whole-genome microarray was used to get an overview of the bacterial gene 
expression of intracellular bacteria. This method is an easy way to collect much 
information at the same time, which allows for further dissection and deeper 
analysis of specific genes of interest.  We had the opportunity to perform these 
studies in collaboration with Prof. Malak Kotb, who has access to customized 
serotype-specific arrays for the clinical isolate that we are working with. 
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4 RESULTS	  AND	  DISCUSSION	  
	  
This part comprises a discussion of the results achieved in the papers on which 
this thesis is based. The first section focuses on intracellular S. pyogenes in 
human macrophages and our finding that they can avoid lysosomal 
degradation. The second part describes intracellular replication and how 
intracellular bacteria later egress out of the cells leading to continued infection. 
The third section highlights gene expression of intracellular S. pyogenes and 
regulation of virulence factors important for intracellular survival. Finally, the 
influence of host-derived PGE2 to intracellular survival is discussed in the last 
section. Paper I-III can be read in full at the end of this thesis.  
 
 
4.1 	  INTRACELLULAR	  TRAFFICKING	  AND	  SURVIVAL	  STRATEGIES	  
S. pyogenes is classically considered as an extracellular pathogen. However, 
during the last decades it has become evident that it is capable of surviving 
inside a number of cell types in different tissues. Highly invasive clones have 
emerged with the ability to cause severe infections raising the number of critical 
S. pyogenes infections, especially in the western communities. In particular, the 
M1 and the M3 strains have been isolated from patients with severe invasive 
infections (78, 112, 115, 242).  
	  
The first evidence of invasion and intracellular persistence was shown in 
respiratory epithelial cells in the mid 1990’s (195, 196). Since then, a variety of 
cells have been studied in relation to invasion and intracellular survival. During 
in vitro studies of PMNs it has been shown that S. pyogenes can resist fusion 
of azurophilic granules (74, 179). Thulin et al. (179), investigated a large 
collection of biopsies from patients suffering from severe tissue infections, 
including necrotizing fasciitis and severe cellulitis, caused by S. pyogenes. 
Results from this study revealed that the bacteria could survive in the tissue 
despite prolonged antibiotic treatment. Detailed analysis of the tissue 
demonstrated viable bacteria harboring inside cells, and furthermore, 
characterization of the cells revealed that the main host cell for S. pyogenes at 
the tissue site are macrophages (179). The intracellular bacterial survival could 
also be verified in an in vitro infection model (179). This was the first evidence 
that S. pyogenes can persist inside macrophages during severe acute 
infections; thus, highlighting a problem with antibiotic eradication of S. 
pyogenes at the tissue site of infection and need for improved future treatment 
strategies for these severe invasive infections.  
 
The aim with this project was to identify streptococcal survival strategies and 
bacterial factors contributing to the persistence seen in the biopsy material. The 
in vitro model previously established was further developed and used in 
detailed kinetic assays to monitor uptake and intracellular trafficking of S. 
pyogenes over time. Cells were infected with a clinical isolate of M1 serotype 
from a patient suffering from STSS (89). Transmission electron microscopy 
(TEM) was employed to get a detailed insight to the bacterial entry process. 
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The analyses revealed that the bacteria are taken up via formation of long 
spacious pseudopod loops that are encircling the pathogen, translocating it to 
the cellular membrane (Figure 1A and 1B, paper I). This mechanism has 
previously been reported to describe the uptake of Francisella tularensis into 
human macrophages (73). Many uptake mechanisms involve reformation of the 
cellular membrane including rearrangement of the actin cytoskeleton. Hence, 
we assessed actin-dependency and found that the bacteria associate with the 
filaments and that blocking of actin polymerization inhibited uptake significantly 
(Figure 1D and 1E, paper I), indicating the participation of the host cell 
machinery for efficient S. pyogenes intake. Involvement of actin filaments has 
previously been reported for S. pyogenes uptake into epithelial and endothelial 
cells (197, 201). However, a study comparing fibronectin-binding protein 
Sfb1+/- strains reported an actin-independent uptake mechanism of the Sfb1+ 
strain in contrast to an actin-dependent uptake of the Sfb1- strain into epithelial 
cells (243). In light of this, it is important to consider differences among 
streptococcal strains in their expression of surface molecules, which may affect 
entry processes. The M1 strains, which is the serotype used in this study, do 
not express Sfb1, which could explain their actin-dependency. Similarly, actin-
dependency was recently reported for an M3 serotype, also lacking SfbI, during 
invasion of endothelial cells (202). Other bacterial strains relying on an actin-
dependent uptake include Salmonella and Brucella (244). Legionella and 
Francisella utilize actin in addition to complement receptor binding and the 
presence of complement factor C3 (73, 212).  
 
Furthermore, assessment of the intracellular location revealed that S. pyogenes 
are contained in membrane-surrounded compartments where they remain 
during the entire infection until dissemination (Figure 2A, paper I). At no time 
point was S. pyogenes found in the cytosol (paper I), in contrast to results 
reported for S. pyogenes in human pharyngeal epithelial cells, where secretion 
of SLO enable bacterial escape from the phagosome to the cytosol (145). Upon 
encounter of a pathogen, macrophages normally engulf and transfer the foreign 
particle through the endosomal-lysosomal degradation pathway for final 
destruction in the phagolysosome, and as described earlier, many bacterial 
species have evolved mechanisms to circumvent their destruction (71). To 
assess S. pyogenes intracellular trafficking, detailed analysis of kinetic 
experiments using antibodies specific for different markers of the endosomal-
lysosomal pathway was conducted. Following uptake S. pyogenes associate 
with the early endosomes up to 15 minutes post infection but at later time 
points post-infection, when pathogens are normally located in the 
phagolysosome, S. pyogenes are to be found in vacuoles distinct from the 
phagolysosomes, Figure 7 (Figure 2B, 2C and 2D, paper I).  
 
 
 
 
 
 
 
 
 
 
  32 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. Confocal pictures of GFP-expressing S. pyogenes inside human macrophages 1h 
post infection. S. pyogenes are located separated from phagolysosomal compartments in red.  
 
 
In fact, they were residing inside actin-surrounded compartments at late time 
points post infection (unpublished data) which is in line with a strategy 
previously reported to be essential for Salmonella typhimurium (245). That 
study showed that S. typhimurium, via a pathogenicity island distinct from the 
one inducing actin-dependent uptake, induces formation of actin filaments 
surrounding the bacteria. This actin-containing vacuole offer the bacteria a safe 
niche as experiments with an actin-depolymerising drug reduced the number of 
bacteria inside the vacuole and negatively affected replication (245).  
 
Avoidance of phagosomal maturation by inhibiting fusion of lysosomal vesicles 
with the phagosome at various stages of the maturation process is a method 
employed by intracellular Salmonella, Brucella and Legionella, visualized in 
Figure 1 in the introduction (211, 246, 247). F. tularensis traffics the endosomal 
pathway similarly to S. pyogenes as they also transiently associate with the 
early endosomal compartment. However, in contrast to S. pyogenes, the 
Francisella-containing vesicle progress to associate with late endosomal 
markers and upon acidification it rapidly burst to release the bacteria in the 
cytosol at approximately 3h of infection. The released particles can then 
replicate in the cytosol (228).  
 
Several intracellular bacterial species have developed sophisticated 
machineries, which secrete effector molecules in order to facilitate invasion and 
intracellular survival, such as T3SS found in Salmonella and Shigella, T4SS in 
Legionella and type six – like secretion system found in Francisella (248-251). 
These effector molecules can, in addition to enhancing bacterial entry, also 
affect signal transduction and modulate host cell responses to the intruders 
favor. S. pyogenes has no known secretion system like the ones found in 
Gram-negative bacteria. However, based on our results demonstrating 
impaired lysosomal fusion, an interesting candidate molecule to explore was 
the M-protein, which has been implicated in resistance to phagosomal 
maturation in human PMNs (198, 199). To this end we employed a M1-protein 
deficient isogenic mutant (ΔM1) in our infection system.  M1-protein was shown 
to be an essential component for intracellular survival as significantly (P < 0.03) 
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lower counts were recovered following infection with the mutant as compared to 
the wild type (wt) (Figure 3A and 3B, paper I). Recent data using a 
complemented ΔM1-strain restored that function, resulting in high numbers of 
surviving bacteria (Hertzén et al., unpublished).  
 
In order to get a more detailed view of the vesicle containing the mutant, we 
used transmission electron microscopy. The electron micrographs revealed 
fusion events of vacuoles with ΔM1 S. pyogenes-containing phagosomes, 
something that was not seen in phagosomes with wt bacteria (Figure 3C and 
3D, paper I). Similarly, in confocal microscopy analysis, the M1-mutant, but not 
the wt co-localized with phagolysosomal compartments (Figure 3E and 3F, 
paper I). Thus, our data demonstrates that M1-protein is required for 
prevention of phagosomal maturation in macrophages. This is in line with what 
has been previously shown during S. pyogenes infection in PMNs (198-200). 
However, the bacterial strain used in the PMN studies is deficient in the whole 
mga operon, resulting in defective expression of protein H (an M-like protein), 
SIC and C5a peptidase in addition to M1-protein. The data in paper I directly 
implicates M1-protein in this process. In the study by Nordenfelt et al., the aim 
was to identify the mechanism behind M1-protein mediated impaired lysosomal 
fusion with a special focus on azurophilic granules. To this end, they used the 
human promyelocytic cell line, HL-60, which has functional azurophilic granules 
but lacks specific granules normally involved in maturation of the phagosome 
(200). In conclusion, much remains to be elucidated regarding the exact 
molecular mechanisms involved in steering the phagosomal maturation. 
 
The inflammatory response towards foreign particles is classically regulated by 
NF-κB. Microbial products or IFN-γ induce activation of intracellular signaling, 
which results in phosphorylation of NF-kB (59). Activation of the inflammatory 
pathway can thereby be studied by investigating the phosphorylation status of 
NF-kB components.  The p65 subunit is an activating unit while the p50 and 
p52 homodimers are repressors lacking a transcription activation domain. 
Many intracellular bacteria are able to modulate the host cell response to 
infection. Normally, a pro-inflammatory reaction is induced with a release of a 
variety of cytokines and chemokines to activate and recruit more immune cells 
to the site of infection. However, this response can be affected in different 
ways. A recent study showed that p50 regulation induces an M2 macrophage 
phenotype, thereby creating an anti-inflammatory response (62). Studying wt 
and ΔM1 S. pyogenes infection of macrophages revealed that wt bacteria 
suppress activation of the NF-kB induced host response as compared to ΔM1 
bacteria, which showed significantly higher phosphorylation of both IκBα and 
p65 (Figure 4, paper I). Additional gene expression experiments supported this 
finding, as TNF-α levels were 8-fold higher in the ΔM1 as compared to the wt 
bacteria (paper I). Thus, M1-protein can be considered as a virulence factor 
modulating the host-cell inflammatory signaling during infection, which is 
important in the defense against intracellular pathogens. Other bacterial 
species that interfere with macrophage polarization include among others, 
Salmonella species that suppress M1 polarized cytokine production of IL-12 
(252), Brucella inhibiting TNF production (253) and Mycobacteria which inhibit 
induction of NF-kB activation (215). A microarray study of S. pyogenes infected 
murine macrophages showed a mixed response with up-regulation in both M1 
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and M2 associated genes (254). It is tempting to speculate that this may reflect 
differences in infected versus uninfected cells, so that the infected cells are 
those displaying the M2 phenotype whereas uninfected the M1 phenotype. It 
would be of interest to further investigate this by isolation of a pure population 
of infected cells by sorting on fluorescently labelled intracellular bacteria. 
 
In Paper I we demonstrate mechanisms underlying S. pyogenes entry and 
intracellular survival in human macrophages. It is interesting that M1-
expressing S. pyogenes are taken up by an actin-dependent mechanism, as 
has also been shown for M3 S. pyogenes (202), which both lack the SfbI 
protein that normally induce fibronectin-mediated uptake. Future studies should 
aim to decipher the receptors involved in this process. M1-expressing S. 
pyogenes encode the FbaA protein whereas M3-expressing bacteria have the 
FbaB protein. Uptake of M1-expressing S. pyogenes to epithelial cells have 
been reported to bridge fibronectin or laminin with M1-protein (255). However, 
bacterial entry into macrophages is not dependent on M1-protein expression 
(paper I).  Upon entry, S. pyogenes is transiently associated with the 
endosomal compartments but can via expression of the M1-protein direct the 
phagosomal trafficking to avoid fusion with lysosomal vesicles. The importance 
of M1-protein further emphasized by its ability to modulate the host cell 
signaling and thereby reduce the pro-inflammatory response. The first part of 
Paper I underscores the importance of M1-protein for intracellular survival in 
human macrophages. In the next section I will describe findings that enable 
further understanding of the intracellular stage of infection and dissemination of 
S. pyogenes.    
	  
4.2 	  	  	  INTRACELLULAR	  REPLICATION	  AND	  SPREAD	  OF	  THE	  INFECTION	  
A previous report from the host lab showed frequencies of intracellular 
streptococci in macrophages that implied a potential intracellular multiplication 
(179). This was further addressed in paper I, where a six log increase, 
compared to initial inoculum, was noticed when quantifying the number of 
bacteria over time (Figure 3B). TEM was used to clarify this phenomenon and 
electron micrographs revealed the characteristic septum of dividing bacteria 
inside macrophages (Figure 5D, paper I). S. pyogenes are still contained in 
membrane-bound compartments upon replication, in contrast to F. tularensis 
that is taken up by a similar mechanism. Currently, we don’t know how 
acquisition of substrates for replication is achieved within the vacuole. Further 
studies are needed to address this. It is clearly so that S. pyogenes express a 
unique gene profile during the early stages of infection, which likely promote 
survival and replication, paper II discussed below. Other bacterial species 
utilize proteins from the ER to form the replicative compartment, such as 
Legionella (256) and Brucella (257) that can be visualized for example by 
immunoflourescent stainings of infected cells or by fractionation and western 
blot staining. As mentioned previously, S. typhimurium requires an actin-
containing replicative niche in order to multiply (245), this type of actin-
dependency would be interesting to investigate during S. pyogenes infection, 
as we have seen that they are contained within such a compartment at late 
time points post infection (unpublished data).   
 
  35 
However, at 6-8 hours after infection, a shift in morphology of the bacterial 
compartments can be noticed. The membranes of compartments with wt 
bacteria appear less dense and not equally tight fitted around the bacteria, as 
compared to ΔM1 or paraformaldehyde (PFA)-fixed wt bacteria (Figure 3C, 3D, 
5A, 5B and 5C, paper I), thereby indicating that the bacterial dissemination is 
an active process. Accordingly, membranes of phagosomes containing wt-
bacteria are dissolving and bacteria are egressing out of the cells (Figure 5A, 
paper I). At late time points post-infection, host cells are completely dissolved 
(Figure 5A, paper I). However, cells infected with the ΔM1 mutant or PFA-fixed 
wt bacteria did not show any morphology changes at later time points post-
infection (Figure 5B and 5C, paper I). To further analyze the functional 
outcome of S. pyogenes infection, discharge of the cytosolic enzyme 
lactodehydrogenase (LDH) from host cells was quantified. Consequently, wt S. 
pyogenes infection induce a time-dependent release of LDH, indicating a loss 
of integrity of the cellular membrane, which was not seen in uninfected cells 
over time (Figure 5E and 5F, paper I). This has previously been reported in 
human monocytes and PMNs upon S. pyogenes infection (147). Recent 
studies have pointed out SLO as a major factor inducing host cell death of 
macrophages via apoptosis or oncosis (146, 147). Another lysine that has been 
shown to be important for bacterial intracellular life is the Listeriolysin O from 
Gram-positive Listeria, which results in escape from the phagosomes in to the 
cytosol (39).    
 
In the studies describing the death-inducing effect of SLO mentioned above, 
killing was seen more rapidly, at three hours post infection as opposed to our 
results of cell death from 8 to 12 hours post infection. This difference in time 
may be explained by utilization of differential infection systems. In the studies 
described, murine macrophages, a human monocytic cell line and human 
blood-derived monocytes were used whereas we have been using human 
monocyte-derived macrophages throughout our studies. The rationale for using 
human macrophages is that it is the predominant host cell for S. pyogenes 
during severe invasive infections which was identified in human biopsies and 
was then hypothesized as being an intracellular source of bacteria in the tissue 
(179).  
 
A clinically important question that was obvious to answer was; are the bacteria 
able to re-infect surrounding cells after dissemination from the host cells? The 
previous reports of viable intracellular S. pyogenes in patient biopsies and in 
vitro (179) pointed to an intracellular source that might contribute to 
dissemination and continued infection. Accordingly, an in vitro model system of 
dissemination was established, and the results showed that intracellular S. 
pyogenes are able to migrate out of the primary infected cells and re-infect 
neighboring cells, thereby spreading the infection (Figure 5G, paper I).  
 
S. pyogenes used to be considered as an extracellular pathogen. The findings 
presented in paper I add on to the recent appreciation that they can survive 
inside phagocytic cells. Avoidance of phagosomal maturation is a pre-requisite 
for survival and is dependent on expression of M1-protein. The bacteria 
replicate in membrane-surrounded compartments as visualized by TEM and 
the increase in bacterial numbers can be quantified by plating of supernatants. 
Finally an increase of LDH in the supernatant as well as morphological 
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changes of the host cells reveled that they are being lysed. Importantly, the 
bacterial survival enable dissemination of the infection since it was shown that 
primary infected macrophages can release bacteria to infect surrounding cells, 
thereby closing the infection circle as visualized below in Figure 8. 
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Figure 8. Infection cycle of invasive S. pyogenes	  
	  
	  
	  
4.3 	  	  GENE	  REGULATION	  IN	  INTRACELLULAR	  S.	  PYOGENES	  
During infection S. pyogenes regulate expression of its virulence factors in a 
very distinct manner. The different sensing components and mechanisms of 
regulation enable bacterial adaptation to the changing environment throughout 
infection (162). The two most common mechanisms of controlling gene 
expression utilized by S. pyogenes are the stand-alone regulators and the 
TCSs that together fine-tune the bacterial response and survival within the host 
cell (162).	   	  As described above, we could demonstrate the importance of M1-
protein for survival in macrophages.	  Gene expression of S. pyogenes grown in 
human whole blood (166), serum (164) and several murine (258, 259) and 
monkey (260, 261) in vivo models have revealed some insight into 
streptococcal pathogenesis. However, there are no studies, to our knowledge, 
on bacterial gene expression during intracellular survival in human 
macrophages.  
 
In paper II we used customized microarrays with printed oligomers of the M1T1 
strain 5448 and quantitative real-time PCR to study the gene expression of 
intracellular S. pyogenes in human macrophages. The microarray technique is 
powerful as it enables analysis of the whole bacterial genome at once, resulting 
in an overview of the gene expression.    
 
As we aimed to target the early time point of the infection process when 
bacteria are adapting to the intracellular compartment as well as preparing for 
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replication, gene expression was determined at 2h post infection of human 
macrophages. At this time point, 145 genes were differentially expressed as 
compared to extracellular bacteria (Figure 1A, paper II). In another study, 
investigating the gene expression of intracellular S. pyogenes in human PMNs, 
276 genes were differentially transcribed at three hours of infection (182). As in 
our study, the largest group, when dividing these genes into functional 
categories, contained hypothetical genes (Figure 1B, paper II) (182). However, 
of the ones with a known function, the major categories of up-regulated genes 
were those involved in cell wall synthesis and energy production (Figure 1B, 
paper II). In addition, also a group of phage-encoded genes were up-regulated 
(Figure 1B, paper II). A common way to transfer virulence factors between 
bacteria is via transposable genetic elements, such as bacterial phages (262). 
Comparison of the genomes of the clinical isolate 5448, the strain used in this 
thesis, and the lab strain SF370, both of the M1T1 serotype, revealed a 95% 
homology (263). Interestingly, the majority of the 5% remaining genes were 
phage-related, and more prominent, in the clinical 5448 isolate it is noteworthy 
that 78% of the 5448-specific sequences are shared by two M3 strains, 
MGAS315 and SSI-1, which are also associated with invasive diseases (263). 
Two important phage-encoded virulence factors found in invasive M1 serotype 
are the superantigen SpeA and the DNase Sda1, to which homologs can be 
found also in the invasive M3 subtypes. It has previously been suggested that 
invasive subclones of the same serotype share genetic elements that render 
them more successful infectants (264, 265). 
 
Bacterial metabolism and regulation of import/export of nutrients and virulence 
factors is dependent on several transport systems. An ABC transporter, 
spy2032/2033, was shown to have increased expression at 2h post-infection 
(Figure 2B, paper II), which confirms previous studies of S. pyogenes growth in 
human blood (166). In the former study, expression of spy2032/2033 was 
associated with increased virulence. Up-regulation during infection in 
macrophages was also verified using q-RT-PCR (Figure 2A, paper II). In 
addition, another ABC transporter, specific for iron transport, spy0385, was up-
regulated both in the microarray and in the q-RT-PCR assay (Figure 2B, paper 
II). In a mouse soft-tissue infection model, the PerR iron transport regulator was 
highly up-regulated, underscoring the importance of iron metabolism during 
infection (258). Bacterial growth within the host cell is dependent on efficient 
acquisition of iron (266), why several studies report an increased expression of 
regulators during infection. Also, bacteria deficient in iron regulators are more 
susceptible to oxidative stress (267, 268).  
 
Intracellular bacteria in macrophages showed a down-regulation of genes 
associated with oxidative stress (Figure 1B, paper II), as compared to results 
reported during infection in PMNs, which show both up-regulated genes and 
expression of oxidative species (182, 198). The down-regulation of genes 
involved in oxidative stress during macrophage infection might be explained by 
S. pyogenes inhibiting maturation of the phagosome (paper I), which renders 
activation of oxidative stress-regulated genes unnecessary.  
 
Interestingly, the TCS Ihk/Irr, recently identified to support resistance to 
oxidative stress in PMNs (165, 182), was up-regulated at 2h post-infection 
(Figure 2B, paper II). To verify this up-regulation, RNA from intracellular 
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bacteria was analyzed using q-RT-PCR, which confirmed the increase (Figure 
2A, paper II). Increased expression of ihk/irr has also been reported during in 
vivo infections of murine models and during infection of human blood and 
serum (164, 166, 258). These studies of S. pyogenes, and the fact that Ihk/Irr 
belongs to a conserved family of gene regulators that are found in several 
bacterial species (269, 270), where it has a role in mediating intracellular 
survival, indicate that it is possibly involved in adaptation and in resistance to 
host cell responses during S. pyogenes infections. To further investigate the 
role of Ihk/Irr in the pathogenesis of S. pyogenes infection, we created an 
Ihk/Irr-deficient mutant (ΔIhk/Irr). Interestingly, plating of infection media from 
cells infected with wt or ΔIhk/Irr revealed a significantly reduced number of 
colony forming units from cells infected with the mutant as compared with the 
wt (Figure 3A and 3B paper II), thus implying that Ihk/Irr has a role in survival, 
alternatively in bacterial dissemination. This matter is currently under 
investigation. 
 
During the infection process, bacteria regulate virulence factors in a 
sophisticated manner, often specific systems are active at different phases. 
CovR/S is a negative regulator of expression of several virulence factors, such 
as SpeB, SIC, SpyCEP, Ska and Sda1 (271). To further look into the dynamics 
of gene regulation during infection, expression of ihk/irr and the covR/S 
systems were compared by q-RT-PCR, at 2h and 6h post-infection. Here we 
included a later time-point at 6h post-infection, as we hypothesized that a 
different gene expression profile would be required during early adaptation 
phase compared to later phases of infection. Early during infection, ihk/irr was 
up-regulated whereas the expression decreased as the infection proceeded 
(Figure 4B, paper II). The opposite was true for covR/S, which had higher 
activity at 6h of infection as compared to 2h post-infection (Figure 4A, paper II), 
thus demonstrating the temporal expression of different TCSs during various 
stages of infection.  
 
CovR/S is a negative regulator through repression of gene expression (169), 
and it has recently been appreciated that invasive S. pyogenes infections often 
results from strains with a mutation in the covR/S TCS (272). Mutation in 
covR/S results in an invasive phenotype, as the normally repressed virulence 
factors then can be secreted (173, 273). CovS positively regulate SpeB, but 
upon mutation, speB is down-regulated and cannot inhibit the action of the 
secreted virulence factors. This phenotype has recently been reported for 
human clinical isolates (177), importantly, and in contrast to this, analysis of 
SpeB expression in tissue biopsies from human subjects reveal high amounts 
of the protease (179). This reflects the fine-tuned gene regulation during the 
infection process, which is depending on several factors including the location 
and the stage of infection. It may seem contradictory that covR/S is up-
regulated at time of dissemination in this study, since it acts by repressing 
virulence factors. However, one of the known genes to be suppressed by 
CovR/S is hasA, which encodes the hyaluronic capsule. The capsule is a 
potent anti-phagocytic factor, why low encapsulation would increase the 
probability of being phagocytosed by a host cell after dissemination from the 
primary infected cell. This would then be a way of spreading the infection.  
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The M1-protein was naturally an interesting target to analyze, as previous 
studies have shown its importance during the intracellular stage in 
macrophages (paper I) and in PMNs (198, 199). We hypothesized that as the 
bacteria replicate and start to adapt for host cell escape and re-infection of 
surrounding cells, expression of the M1-protein would increase. mRNA 
expression of M1-protein at 2h and 6h of infection revealed a 2-fold increase 
over time (data not shown). It is tempting to speculate that this expression is 
increased at later time points post-infection when the majority of cells are lysed 
and the bacteria demonstrate high capacity to infect new cells. Actually, a 
recent study investigating clinical isolates identified higher expression of M-
protein in M1, M3 and M6 serotypes, which are known to be associated with 
invasive diseases, as compared other serotypes (274). To further analyze the 
functional outcome of differential gene expression, macrophages were infected 
for 2h and 6h, after which they were lysed and new cells were re-infected with 
bacteria from the lysates (see experimental out-line in Figure 9). After 2h of 
infection, lysates from newly infected cells were plated and colony-forming units 
were counted. Preliminary data on infectivity supported the hypothesis that 
bacteria later in the infection stage have better capacity to infect and adapt in 
new host cells, and thereby indicate the importance of differential gene 
expression during the infection process (Figure 4C, paper II).  
 
 
Figure 9. Overview of the experimental set-up. 
 
 
Establishment of an S. pyogenes infection is a complex process that requires 
distinct mechanisms regulating every step. S. pyogenes is a versatile pathogen 
that is able to cause a variety of infections in different tissues, which is possible 
through bacterial adaptation as a reaction on the surrounding environment.  
Gene expression during the intracellular stage of infection of human 
macrophages was investigated in paper II. Overall, the major changes are 
associated with adaptation to the intracellular environment. Two key groups of 
up-regulated genes were those involved in cell wall synthesis and energy 
production. This is also the case during infection in human PMNs (182). 
Additionally, phage-encoded genes were up-regulated, which is likely linked to 
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virulence promotion as well as some transporters important for acquisition of 
metals and nutrients. Studies of specific genes revealed a temporal expression 
of two TCSs, ihk/irr and covR/S, indicating the fine-tuned gene regulation and 
confirming their previously reported importance during infection. Furthermore, 
the functional importance of gene regulation was shown in a survival assay.  
 
In conclusion, intracellular S. pyogenes actively change their expression profile 
as to enable an intracellular persistence. The recent understanding that S. 
pyogenes have the ability to survive intracellularly has opened up a new 
research field with many aspects to explore in regards to gene regulation and 
adaptation. Future experiments aiming to answer these questions will be 
important to improve our understanding of host-pathogen interactions during 
severe S. pyogenes infections.  
 
 
4.4 	  	  COX-­‐2	  EFFECT	  ON	  INTRACELLULAR	  SURVIVAL	  
The two previous studies have focused on uptake, trafficking and intracellular 
survival of S. pyogenes from the bacterial point of view. In Paper III, focus is 
shifted to study how the host cell response can affect S. pyogenes infection. 
Upon infection, the immune system is activated and cells in the surroundings of 
the bacteria start to secrete signaling molecules. One such molecule is PGE2, 
which genes has been shown to be strongly induced upon S. pyogenes 
infection in a susceptible mouse model (67). PGE2 is an arachidonic acid 
metabolite that is produced by various cells in response to inflammation (63) 
and it has previously been showed to facilitate intracellular survival of several 
bacterial species (275, 276). Thus, our aim with paper III was to study the 
effect of PGE2 in S. pyogenes infection.   
 
Firstly, we analyzed biopsies from patients with varying severity of 
streptococcal tissue infection for COX-2, the rate-limiting enzyme converting 
arachidonic acid into PGE2. The results revealed a significant correlation with 
disease severity and amount of COX-2 in the tissue (Figure 1, paper III). 
Similarly, S. pyogenes infection of mice resulted in induction of cox-2 mRNA as 
compared to uninfected controls. Investigation of COX-2 protein in the liver, 
revealed clear staining in infected mice as compared to uninfected (Figure 2B, 
paper III). To ascertain an effect of the COX-2 expressed, the plasma 
concentrations of PGE2 was determined and found to be significantly elevated 
in infected mice. In addition, an inhibitor of COX-2 reduced the levels of PGE2 
to those seen in the plasma of uninfected control mice (Figure 2C, paper III). In 
summary, these experiments show that COX-2 is up-regulated upon S. 
pyogenes infection in an in vivo model and promote PGE2 production.  
 
Activated macrophages have long been known to be potent producers of 
prostaglandin with COX-2 being responsible for processing of the active 
component, PGE2 (277, 278). Indeed, bone marrow (BM) murine macrophages 
were shown to be strong producers of COX-2, shown both at the RNA and 
protein level (Figure 3A and 3B, paper III) and COX-2 could be identified in BM 
murine macrophages and primary human monocytes (Figure 3C and 
supplementary figure 1, paper III).  
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To further decipher the functional role of COX-2 we used an experimental 
model utilizing mice deficient in the COX-2 gene. Infection of the COX-2 -/- mice 
reveled a significant improved survival (Figure 4A, paper III) and no detectable 
PGE2 was present in the serum of infected as compared to wt mice (data not 
shown). Pro-inflammatory cytokines has previously been reported to affect 
disease progression during S. pyogenes infection (279), and in fact, 
investigation of serum levels revealed that COX-2 -/- mice produced 
significantly lower amounts of IL-6 and IFN-γ (Figure 4C and 4D, paper III).  
Based on these results we hypothesized that a COX-2 inhibitor could be a 
potential therapeutic strategy. Consequently, mice were given a COX-2 
inhibitor 2h prior and 4h after S. pyogenes infections, which resulted in 
prolonged survival, lower amount of bacteria in the liver and lower IL-6, IFN-γ 
and TNF-α levels as compared to vehicle-treated mice (Figure 4E, 4F, 4G, 
supplementary figure 3A and 3B, paper III).  
 
In light of our data of intracellular S. pyogenes in macrophages, as well as 
previous reports that PGE2 can inhibit intracellular killing of Pseudomonas 
aeruginosa, Escherichia coli and Klebsiella pneumoniae in macrophages (275, 
276), we wanted to investigate this aspect of PGE2 function in S. pyogenes 
infection of BM macrophages. Indeed, Figure 5A, paper III, shows a clear 
dose-dependent inhibition of bacterial killing in BM macrophages as well as in 
human monocytes (Supplementary figure 4, paper III). These data suggest a 
suppressive effect of PGE2 on intracellular killing.  
 
To study the mechanism by which PGE2 mediated its effect on bacterial 
survival, we investigated the interactions in more detail. The effect of PGE2 can 
be exerted through ligation of four types of membrane bound E prostanoid (EP) 
receptors (EP1-EP4) (280). Identification of the receptor involved in the 
suppressive effect on intracellular survival of S. pyogenes in macrophages was 
achieved through agonist/antagonist assays using compounds blocking the 
PGE2-receptor interaction or replacing PGE2 in the receptor interaction. Those 
studies revealed that EP2 is the receptor mediating the effector function of 
PGE2 in macrophages (Figure 5, paper III). The effect of EP2 inhibition could 
be shown both in vivo and in vitro.  
 
Intracellular signaling via EP2 occurs through cyclic AMP (cAMP) expression 
(64), and investigation of the cAMP levels during S. pyogenes infection in 
macrophages revealed a dose-dependent increase in the intracellular cAMP 
levels (Figure 6A, paper III). Similar amounts of cAMP were found when the 
EP2 agonist, butaprost was used, as compared to the EP3 agonist, 
soprostone, (Figure 6B, paper III).  Functional evidence was gained as addition 
of forskolin or rolipram, known to increase cAMP levels in macrophages, 
resulted in higher numbers of viable intracellular S. pyogenes (Figure 6C and 
6D, paper III).  To identify the molecular mechanism in detail we went further 
down in the signaling cascade. cAMP acts through activation of two 
downstream effector molecules, the protein kinase A (PKA) and the exchange 
protein directly activated by cAMP (Epac) (281). Activation of PKA resulted in 
suppression of antimicrobial effects and consequently higher numbers of 
intracellular bacteria as compared to the levels in non-treated cells. In contrast, 
inhibition of PKA prevented the immune suppressive effect and as a result, less 
bacteria were to be found (Figure 7A, paper III).  
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It has previously been reported that cAMP-activated PKA can inhibit ROS 
release from macrophages (275, 282). Production of ROS by NADPH oxidase 
is one of the major host cell responses to S. pyogenes by macrophages (254). 
We hypothesized that PGE2 bound to EP2 resulting in cAMP-elevation leads to 
PKA activation that finally inhibited formation of ROS. This hypothesis was 
tested through investigation of ROS production in PGE2-treated and non-
treated macrophages. Figure 7B, paper III, clearly shows that PGE2 treated 
cells do not produce ROS while non-treated cells do, thus supporting the 
hypothesis.       
    
In conclusion, prostaglandin secreted from various cells is converted to PGE2 
by the inducible enzyme COX-2. PGE2 binds to the EP2 receptor on the 
macrophage membrane and increase cAMP levels in the cell. cAMP in turn 
activates PKA which have an inhibitory effect on ROS production, resulting in a 
deficient bacterial killing.  
 
 
 
Figure 10. Schematic presentation of the results in paper III. 
 
 
The results from the present study reveal a way to interfere with the 
suppression of ROS-production. Non-steroidal anti-inflammatory drugs 
(NSAID) are commonly used for patients with fever and inflammatory 
symptoms. However, these are non-selective COX inhibitors, which may mask 
initial symptoms of severe S. pyogenes infections and thereby delay correct 
diagnosis resulting in worsening the outcome (283). Therefore it is important to 
use selective inhibitors to target this interaction, which may provide a new 
treatment strategy. Further studies are needed to clarify these mechanisms and 
their clinical outcome.   
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5 CONCLUDING	  REMARKS	  
	  
	  
The studies comprised in this thesis contribute to a deeper understanding of 
the host-pathogen interplay during severe S. pyogenes infections, in particular 
with regards to mechanisms contributing to intracellular survival in host cells. 
The results demonstrate that S. pyogenes ability to persist within macrophages 
is enabled through distinctly regulated mechanisms involving both host and 
bacterial factors.  
 
Certain bacterial serotypes are more efficient in causing invasive infections 
than others, as they are equipped with special tools to facilitate invasion and 
survival. We have identified M1-protein as an important factor for intracellular 
survival in macrophages. The possibilities of S. pyogenes to affect phagosomal 
maturation, thereby creating a safe-haven and replicative niche crucial for 
continued disease progression. The molecular events underlying this 
mechanism and the potential of M1-protein as a target for intervention remain 
to be defined in future studies. Another important question is whether the noted 
phagosomal maturation arrest mediated by the M1-protein is a property shared 
among different M proteins or unique to the M1-protein. Regulation of bacterial 
intracellular signaling is vital for bacterial survival and it also affects host 
responses. Data are supporting a role for the TCS Ihk/Irr during adaption to the 
intracellular environment while CovR/S possibly facilitates increased infectivity 
of disseminating bacteria. In addition, we show that PGE2, which is produced 
upon infection, has a negative impact on macrophage bactericidal responses. 
What can be done to inhibit bacterial persistence and modulation of the host 
cell response? Work presented in this thesis has identified different host and 
bacterial factors that may serve as potential targets for novel therapeutic 
strategies in severe S. pyogenes infections. In addition, host pre-disposition to 
disease progression has to be taken into account and at present, there are 
large knowledge gaps in this area. Future research in this new field is thus 
strongly needed. S. pyogenes used to be considered as an extracellular 
pathogen, however, it is now important to evaluate ways to interfere with its 
intracellular capacity.   
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6 POPULÄRVETENSKAPLIG	  SAMMANFATTNING	  PÅ	  SVENSKA	  
	  
 
Det uppskattas att Streptococcus pyogenes orsakar 500 000 dödsfall varje år, 
vilket ger en världsrankning som nummer nio i listan på de värsta 
infektionssjukdomarna. S. pyogenes är en bakterie som de flesta kommer i 
kontakt med under barndomen då den är en vanlig orsak till halsfluss och 
svinkoppor (impetigo). Man uppskattar att det förekommer 616 miljoner 
halsinfektioner orsakade av S. pyogenes i världen varje år. Dessa infektioner är 
lätta att bota med antibiotika. Emellertid kan S. pyogenes även orsaka 
aggressiva system- och mjukdelsinfektioner, vilka är svårare att behandla och 
som snabbt kan utvecklas till livshotande infektioner.  Dessa infektioner har hög 
dödlighet och morbiditet trots adekvat antibiotikabehandling. Studier av 
vävnadsprover från patienter med dessa allvarliga infektioner påvisade levande 
bakterier inuti immunceller, så kallade makrofager. S. pyogenes kan alltså 
överleva inuti celler och därmed undvika antibiotika samt kroppens eget 
immunförsvar. I denna avhandling har vi kartlagt hur bakterierna kan överleva 
inuti cellerna samt om de använder cellerna som ett slags skyddsrum för att 
kunna tillväxa och sedan sprida infektionen vidare till andra delar av kroppen. 
 
Vi har kunnat se att bakterierna tas upp av cellerna på ett nytt och annorlunda 
sätt jämfört med andra bakterier och när de väl är inne i cellerna uttrycker de 
ett speciellt protein (dvs. M-proteinet) som ger dem möjlighet att manipulera 
cellens sätt att ta död på dem. Vi har också kunnat se att de kan föröka sig inuti 
cellen. S. pyogenes kan även sprida sig till närliggade celler genom att spränga 
cellväggen. För att öka förståelsen för hur S. pyogenes överlever i cellerna så 
tillämpade vi en metod för att undersöka genuttrycket hos bakterierna när de är 
inuti cellerna, så kallad microarray. Vi kunde då konstatera att ämnes-
omsättningen påverkas när bakterien måste anpassa sig till miljön i cellerna 
samt att bakterien uttrycker andra faktorer än utanför vilka bidrar till en ökad 
överlevnadschans. En av de här faktorerna är ett regulatoriskt så kallat två-
komponentssystem, Ihk/Irr, vilket tidigare visats vara viktigt vid överlevnad inuti 
en annan immuncell, neutrofilen. Det verkar alltså ha en central roll för 
streptokockens liv inuti cellen.  
 
Genom att undersöka hur cellen reagerar på infektion har vi även kunnat 
konstatera att bakterien kan dämpa aktivering av cellens immunsvar. Även i en 
musmodell kunde vi även se att bakterien inducerar en celltyp (typ 2 makrofag) 
som inte är kapabel till att bryta ned bakterien och därmed kan den överleva 
inuti cellen.  
 
Sammanfattningsvis kan man säga att vi med de arbeten som ingår i den här 
avhandlingen, har kartlagt specifika faktorer som har betydelse för S. pyogenes 
överlevnad och fortsatta infektion i humana makrofager. Dessa faktorer är 
intressanta som målprotein för utveckling av nya behandlingsmetoder av svåra 
streptockockinfektioner orsakade av S. pyogenes.  
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